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Designed Three-Dimensional Architectures 
 
Stephen A. Habay, PhD 
 
University of Pittsburgh, 2005 
 
 
This dissertation explores the design and synthesis of bis-amino acid molecular building 
blocks and their assembly into small oligomers of designed shape.  Specifically, we investigated 
a class of monomer known as the hydroindole bis-amino acids.  One member of this family, 
hin(2S4R7R9R), provided a sharp turn in three-dimensional space when assembled into 
oligomers.  We employed various strategies to synthesize the hydroindole monomers, including a 
Diels-Alder pathway and an oxidative rearrangement of (L)-tyrosine.   
Larger oligomers containing this building block were modeled and found to have distinct 
compact tertiary structures.  We then carried out the solid phase synthesis of these oligomers, 
composed of the hin(2S4R7R9R) and other monomers, and optimized their rigidification into 
spiro-ladder scaffolds of well defined architectures.  Efforts towards full structural 
characterization of these molecules are also presented here.   
The hydroindole-based bis-amino acid building blocks are an integral part of a larger 
library of monomers that are used to construct water soluble macromolecules of designed shape.  
The ultimate goal of this new technology is to develop these macromolecules into functional 
nano-scale devices that display compact tertiary structures and present chemical functionality for 
use in a wide range of biomimetic and nanotechnology applications. 
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1. Introduction 
 
1.1. An Introduction to Molecular Nanotechnology 
A revolutionary new field of study is currently emerging that promises to combine the 
imagination, creativity and technical expertise of scientists worldwide.  This new field focuses 
the areas of chemistry, physics, biology, materials science and engineering toward one singular 
goal; manipulating matter and arranging atoms with ultimate precision. 
 Although in its infancy, molecular nanotechnology has been placed at the top of the list 
of promising fields of research and development in the United States.  This new field, because of 
its broad interdisciplinary nature, has far-reaching applications and societal implications.  
Envisioned breakthroughs include, but are not limited to, orders-of-magnitude increases in 
computer efficiency, human organ restoration using engineered tissue, “designer” materials 
created from directed assembly of atoms and molecules and renewable and efficient energy 
sources.1    
The properties of all materials are determined predominantly by the arrangement of the 
atoms from which they are composed.  Thus, complete control over the positioning and 
properties of each and every atom would give the scientist great power to develop materials and 
machinery on the nanometer length (one billionth of a meter) scale.2  In essence, the ultimate 
goal of molecular nanotechnology is the creation of useful materials, devices and systems 
through the control of matter on the nano-scale and the exploitation of novel properties and 
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 phenomena developed at that scale.1  The only current useful examples of these nano-scale 
devices are those found within biology in the form of biological proteins and catalytic RNAs. 
Nature’s general solution to constructing nano-scale molecular devices lies in biological 
proteins.  These macromolecules have very powerful catalytic, energy transduction and 
information processing capabilities that arise because of their ability to both encapsulate smaller 
molecules and position functional groups in three-dimensional space with sub-angstrom 
precision.  To apply these aspects of proteins to molecular nanotechnology, science must develop 
the ability to study and construct systematically macromolecules with these capabilities.   
De novo design of unnatural proteins is an active field of research3,4 and has yielded 
many advances in the production of simple α-helical5 and β-sheet proteins, however the 
synthesis of proteins with new functions is only recently just beginning to yield results.6  The 
overwhelming protein folding problem has been the prohibitive factor in these accomplishments.  
One of the great unsolved problems of science is the prediction of the three-dimensional 
structure of a protein from its amino acid sequence.7  Both experimental and theoretical 
approaches8 have been used in the search for a solution, with many promising results9, but no 
general resolution.  Even with all the above mentioned strategies, there is still currently no one 
universal method of building functional macromolecules.  Thus, the question remains: Can large, 
highly functional macromolecules be synthesized in an efficient and engineerable manner that 
approach biological proteins in their function? 
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 1.2. Understanding and Mimicking the Macromolecules of Nature 
To develop unnatural macromolecules that mimic protein structure/function, it is first 
necessary to understand how nature constructs its own oligomers.  Proteins truly are “oligomers” 
that nature constructs from the combination of a limited number of building blocks (~20 amino 
acids).  The amino acid building blocks are connected to one another through single amide 
(peptide) bonds.  The peptide or protein is then a flexible oligomer that must fold into a 
particular conformation before it can perform a biological function (Figure 1).  The essential 
functions of proteins are intrinsically linked to their structure and dynamic switching among 
different conformational states.1  This phenomenon is demonstrated in the open and closed forms 
of ion channel proteins in a membrane.  However, accurately predicting the manner in which a 
protein will fold, from only its amino acid sequence, is currently impossible. 
 
Figure 1: Nature’s assembly of functional macromolecules 
 
 Numerous researchers have undertaken the challenge of creating synthetic oligomers to 
study the relationship between structure and function.15,22,24  Oligomer synthesis is an efficient 
approach to macromolecules because it is modular and allows the rapid assembly of large 
structures from a collection of small monomers.  This research has spawned an entirely new field 
of inquiry known as “foldamers.”  A foldamer is defined as “any oligomer that folds into a 
3 
 conformationally ordered state in solution, the structures of which are stabilized by a collection 
of noncovalent interactions between nonadjacent monomer units.”10  Many groups11, ,12 13 are 
currently developing unnatural monomers that are assembled through single bonds to form 
foldamers (Figure 2).  These foldamers have strong tendencies to form well-defined secondary 
structures through the influence of weak noncovalent interactions.10, , , ,14 15 16 17   
 
Figure 2: Examples of monomer subunits of foldamers 
 
 One type of foldamer that has been extensively studied18, ,19 15 and has a potential for 
applications in nanotechnology is that of the β-peptide.  β-peptides have a particular appeal for 
extending the understanding of protein structure and stabilization into the realm of folded, 
nonbiological polymers, because β-amino acids represent the smallest step away from α-amino 
acids in “backbone space.”18  Like α-peptides (i.e., peptides composed of α-amino acids), β-
peptides contain amide bonds capable of forming stabilizing, intramolecular hydrogen bonds.18  
4 
 As such, various types of β-peptides will have certain secondary structural characteristics that 
can be pre-determined in a “molecular engineering” manner.   
 Gellman and coworkers20 are pioneers in the area of β-peptides and have observed the α-
helical nature of these molecules both in the liquid and solid state.  β-peptides have also been 
found to display useful biological functions.20,21  In fact, it was discovered by Gellman’s group 
that certain helical, cationic and amphiphilic β-oligomers had antibiotic function.21
 From these β-peptides and other molecules, Gellman wishes to design foldamers that may 
mimic certain secondary structures, and eventually tertiary structures, of proteins in an 
engineerable fashion.  Because the folding patterns of proteins generate “active sites” via precise 
three-dimensional arrangements of functional groups, it is proposed by Gellman that control over 
the secondary structural units in a folding polymer will lead to tertiary structural control.22  Thus, 
it should be possible for the chemist to design functional polymers with biological, catalytic and 
organizational properties not precedented in nature.20  However, there are currently no 
experimental results that support Gellman’s hypothesis of secondary structural control leading to 
tertiary structural control.  Designable, functional oligomers would be a tremendous advance for 
molecular nanotechnology, but one would still need to identify new polymeric backbones with 
suitable folding propensities, functionalize the backbones and be able to generate these materials 
efficiently; a series of tasks that even Gellman admits is daunting at best.22
There has been some success at generating folding oligomers that contain small cavities.  
Moore and coworkers have demonstrated that their folding phenylene ethynylene oligomers form 
helical secondary structural motifs23 in certain solvents that can bind a variety of small molecule 
guests, including methyl iodide24 and piperazinium dihydrochloride salts.25 These intriguing, 
5 
 cavity-containing oligomers have enormous potential to develop into supramolecular catalysts26, 
nonetheless, they have yet to demonstrate any catalytic activity.  
An obvious next step in the evolution of foldamer research, then would be to design and 
build “larger, more complex chain molecules capable of folding into truly tertiary structures or 
structures having long-range intrachain energetic interactions.”10  These tertiary structures must 
be able to bind small molecule guests to promote biomimetic applications.  Clearly much 
intensive work on this problem will be necessary for any future applications to be developed.  A 
new set of folding rules will have to be elucidated for each new oligomer designed and a more 
efficient method of assembling macromolecules with designed tertiary structures needs to be 
developed.  This method must provide oligomers with three-dimensional architectures that are 
predictable and designable without the necessity of deducing how the structure will fold.  The 
design and construction of such tertiary structures is the focus of this dissertation. 
1.3. A Novel Method for the Synthesis of Macromolecules with Designed Structures 
To circumvent the protein folding problem, oligomers can be constructed from monomers 
that are assembled through pairs of bonds (Figure 3).  The structures of these molecular 
architectures would depend predominantly upon the intrinsic rigidity and absolute 
stereochemistry of each building block from which they are composed.  These structures will not 
fold but, instead, adopt complex conformations that are fixed and predictable.   
6 
  
Figure 3: Cartoon of our approach to the construction of macromolecules with designed shapes 
 
 The molecular building blocks necessary to accomplish this task must be 
stereochemically pure, cyclic, and easy to synthesize from inexpensive commercially available 
materials.   For biomimetic and nanotechnological applications, it is also imperative to mimic 
some of the properties of proteins (e.g., water solubility, compact structure, etc.).  Whereas 
proteins are assembled from a sequence of amino acid building blocks coupled through one 
amide bond, these oligomers are constructed from a sequence of bis-amino acid building blocks 
coupled through two amide bonds.  As a result, these monomers hold each of its two adjacent 
partners in a particular three-dimensional conformation connected through a rigid 
diketopiperazine linkage (Figure 4). 
N
CO2H
FmocHN
MeO2C
Cbz
A simple molecular
building block...
N
HN
N
O
O
O HN
N
O
O
N
H
NO
O
A 3-mer connected through 
diketopiperazine linkages.  
Figure 4: A proline based monomer coupled to two adjacent partners through pairs of amide bonds 
 
The diketopiperazine moiety is the result of a well known side reaction in both solid phase and 
solution phase peptide chemistry.27,28 They are formed by the intramolecular cyclization of the 
7 
 growing peptide chain.  The reaction is thermodynamically favored27 with a half life that 
depends on the molecular context and conditions, but can range from seconds to days.28    
 A variety of building blocks have been synthesized29, ,  30 31 (Figure 5) that provide 
numerous structural features to the rigidified oligomers, such as extending rods, sharp turns, and 
helical pitch.  As the number of monomers in our library increases, the number of oligomers that 
can be synthesized from those building blocks grows exponentially.  Thus, for example, if we 
were to synthesize sequences of ten monomers from just four molecular building blocks, we 
could construct 410 (~1,000,000) different shapes.  From this enormous collection of potential 
structures, sequences that have interesting properties could be selected.  The overall method is 
comparable to foldamer construction and de novo protein design, but without having to solve the 
complex folding problem. 
N
N
N
H
H
NHFmocNHPhF
HN
Cbz
O
HO
O
OMe
Cbz
O
HO
O
MeO
O
OH
Cbz
O
MeO
Fmoc
hin(2S4R7R9R)
"sharp turn"
pro4(2S4S)
"extending rod"
pip5(2S5S)
"helical pitch"  
Figure 5: A small library of bis-amino acid monomers 
 
The oligomers can be designed a priori on software developed in our laboratory (Figure 
6).  The Computer Aided Nanostructure Design and Optimization (CANDO) program32 is used 
in conjunction with the molecular mechanics package MOE33 to design and predict various 
oligomer conformations of interest.  The synthesis of the modeled oligomer is then carried out in 
the laboratory and the solution structure determined by NMR spectroscopy or, perhaps, the solid 
8 
 state structure can be obtained by X-ray crystal diffraction.  The structural predictions are then 
compared with the experimental data to better improve the computer software precision. 
 
Figure 6: CANDO software 
 
 Our long term goal is to rapidly design, synthesize, and study macromolecules that have 
compact tertiary structures and contain small-molecule sized cavities.  There are essentially 
limitless applications for these oligomers.  For instance, in the area of biomimetic chemistry, the 
efficient catalysis carried out by nature’s enzymes has influenced researchers to imitate it in the 
laboratory.34  Enzymes tend to bind small molecule substrates and then catalyze a chemical 
reaction performed on that substrate in the binding pocket.  The ability to accurately position 
catalytically active functional groups inside of a cavity-containing macromolecule will greatly 
facilitate enzyme mimetics.  To meet this goal our oligomers must be able to form designed 
cavity structures for binding small molecules and be constructed from a sequence of molecular 
building blocks that contain functional groups properly positioned to perform the catalytic 
function.  We believe that this can be accomplished using our synthetic and computational 
methods. 
9 
  In the realm of molecular manufacturing applications, i.e. nanotechnology, there is an 
opportunity for the development of molecular machinery, nano-scale tools, and devices.  To 
manufacture products on the nano-scale, precise control over the shape and rigidity of the 
macromolecules is essential.  Positional assembly, as opposed to self assembly, is a relatively 
unexplored method of molecular manufacturing with organic materials.35  Positional assembly 
requires stiff materials that maintain a shape-persistent architecture, unlike foldamers and 
supramolecular complexes.  By connecting our molecular building blocks through pairs of 
covalent bonds, we obtain a level of rigidity unlike almost any other organic macromolecule.   
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 2. A Diels-Alder Approach to the Synthesis of Molecular Building Blocks 
 
2.1. Introduction 
To construct rigid oligomers that can display chemical functionality in three-dimensional 
space, it is first necessary to have the component building blocks in hand.  Unlike target directed 
natural product synthesis, there is an inherent flexibility in what can be chosen as a molecular 
building block.  The ideal properties of a monomer are synthetic accessibility (can be 
synthesized in fewer than 10-12 steps), stereochemical purity, and synthetic flexibility (easily 
functionalized).  Most importantly, however, is the monomer’s ability to provide a unique 
architectural shape when coupled to its two adjacent partners.   
Because the syntheses are short, it allows for the quick testing of synthetic pathways.  If 
separation methods can be developed, weakly diastereoselective reactions and racemic syntheses 
can be used because each stereoisomer produced leads to a new building block.  As part of this 
methodology for the synthesis of molecular building blocks, the Diels-Alder reaction can be 
considered a potentially valuable reaction. 
The Diels-Alder [4+2π] cycloaddition reaction (DA reaction) is particularly useful, due to 
its high regio- and stereo-selectivity and for the wide variety of functional groups that can be 
tolerated.36  This reaction also allows the construction of molecular building blocks through a 
convergent method rather than a stepwise synthesis.  Although, the reaction could conceivably 
give rise to a number of structural or stereo isomers, usually one isomer is formed exclusively or 
at least in predominant amount.37  Nonetheless, any and all stereo isomers generated from these 
syntheses would be utilized. 
11 
 For the purposes of designing bis-amino acid monomers, this particularly useful ring-
forming reaction allows the generation of rigid carbo- and heterocycles by the reaction of a 
protected amino acid diene with a masked amino acid dienophile (Figure 7).  Of course, the 
success of this reaction depends largely upon the proper matching of the frontier molecular 
orbital energies of the diene and dienophile.  Initially, it will be difficult to decipher such 
energies because there is little precedent for DA reactions between these types of DA 
components. 
NR
1O2C
P1
NHP2
CO2R2
n
N
P1
R1O2C
NHP2
CO2R2
n
**
**
*
 
Figure 7: bis-Amino acid DA example. 
 
 Two initially desired types of building blocks were conceived.  The first, “hydroindole” 
class of monomer (Figure 8), provides a gentle three-dimensional turn, in the cis configuration, 
and has multiple points of possible substitution for adding masked functional groups on the 
oligomer.  This monomer is perfectly well suited for construction via the Diels-Alder method.  
Lending confidence to this method, similar ring systems were synthesized by Speckamp38 and 
Cha39,40 utilizing DA reactions under mild conditions in good yields. 
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 N
Ns
HO2C
H
H
CO2Me
NHFmoc
A B C
N
H
H
H
N
NO
H
O
HN
H
O
O
N
H
HN
NH
O O
HN O
O
2 64
9
 
Figure 8: (A) One isomer of the hydroindole monomer.  (B) An oligomer composed of the sequence 
pro4(2S4S)-hin(2S4R6R9R)-pro4(2S4S).  (C) An energy minimized stereo view of the turn induced by the 
hin(2S4R6R9R) monomer. 
 
The “azabicyclooctane” based molecular building block is a second desirable monomer 
(Figure 9).  The substructure of the monomer contains a very rigid, fused aza-bicycle that 
provides excellent structural support for any oligomer from which it is synthesized and induces a 
sharp turn in three-dimensional space.  Moreover, several points of further functionalization are 
accessible on the molecule. 
N
O
Boc
HO2C
H NHFmoc
CO2Me
N
O
H
HN
O
O
N
HN
O
O
H
H
N
NO
O
HN
NH
H
O
OA B C
1
3
2
4
5
6
7
8
 
Figure 9: (A) One isomer of the bicyclooctane monomer.  (B) An oligomer composed of the sequence 
pro4(2S4S)-2abco(1S3R4S7R)-pro4(2S4S).  (C) An energy minimized stereo view of the sharp turn induced 
by the 2abco(1S3R4S7R) monomer. 
Similar isonuclidine ring structures have been synthesized, utilizing a dihydropyridine 
moiety as the diene component of the DA reaction with various dienophiles, by both Raucher41 
and Matsumura.42  Considering these methods as precedent, it should be possible to carry out the 
DA reaction of an electron rich, chiral dihydropyridine with a dehydroamino acid with excellent 
13 
 regioselectivity.  If the dehydroamino acid does not undergo DA reaction there are alternatives, 
such as methylene Meldrum’s acid, that may be more reactive.  The endo/exo selectivity, 
however, is undetermined.  Regardless, all potential isomeric products are useful.  Most 
importantly, the precedent of the DA reaction applied to the synthesis of rigid bis-amino acid 
compounds would facilitate the production of other bis-amino acid monomers. 
2.2. Hydroindole Monomer 
 
2.2.1. Retrosynthetic Analysis 
In light of the Diels-Alder approach to constructing molecular building blocks, a 
retrosynthetic analysis of the hydroindole monomer 1 (Scheme 1) reveals that it can be derived 
from enamide 2, resulting from a DA reaction of the appropriate diene 3, and dienophile 4.  
Although both fragments undergo DA reactions separately, and under various conditions, the DA 
reaction here is unprecedented.   
N
Ns
CO2Me
NHFmoc
HO2C
N
Ns
CO2Me
NHFmoc
t-BuO2C
N
Ns
t-BuO2C NHFmoc
CO2Me1 2
3
4  
Scheme 1: Retrosynthesis of hydroindole monomer 1 
 
 Accordingly, the next step in the retrosynthetic analysis leads to alkynamide intermediate 
5 (Scheme 2).  Witulski43 and Mori44 have both shown that such N-ethynylamides are readily 
available from the corresponding sulfonamides (derived from (R)-allyl glycine 6) via alkylation 
with ethynyl(phenyl)iodonium triflate.  The dienophilic dehydroalanine 4 is easily prepared from 
commercially available serine. 
14 
 N
Ns
t-BuO2C
3
Nt-BuO2C
Ns
NH2HO2C
5 6
NHFmoc
CO2Me
4
Serine
(R)-Allyl Glycine
 
Scheme 2: Retrosynthesis of diene 3 and dienophile 4 
 
2.2.2. Results and Discussion 
The diene component of the hydroindole monomer was synthesized from (R)-allyl 
glycine, prepared in large quantities by the method of Myers.45  With the appropriate starting 
material in hand, the synthesis began (Scheme 3) with the protection of the amino end of (R)-
allyl glycine with Fukuyama’s46 2-nitrobenzene sulfonyl (Ns = nosyl) protecting group.47  The 
reaction proceeded smoothly to give the nosyl protected allyl glycine 7 in excellent yield (93 %).  
This material was then protected as the t-butyl ester using the isobutylene method of Anderson48 
to yield 8 in excellent yield (92 %).  The fully protected amino acid was then N-alkynylated43 to 
compound 9 with commercially available ethynyl(phenyl)iodonium tetrafluoroborate.49   
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Scheme 3: Diene synthesis 
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 Ruthenium catalyzed enyne metathesis44 of compound 9 was induced by treatment with five 
mole percent of Grubbs second generation catalyst in anhydrous toluene at 80 °C.  The ene-
ynamide was smoothly converted to the corresponding diene 3 in good yield (86 %) in only 15 
minutes.  The diene was then crystallized to yellow florets from ethyl acetate/hexanes.  This 
dienamide moiety 3 is analogous to Mori’s44 substrate which was utilized for DA reactions with 
a variety of dienophiles (Scheme 4). 
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Scheme 4: DA reactions of Mori’s dienamide substrate 
 
 The dienophilic component 4 (Scheme 5) was subsequently synthesized from serine 
methyl ester hydrochloride by 9-fluorenylmethyloxy carbonyl (Fmoc) protection47 of the amino 
group followed by elimination of the corresponding mesylate intermediate50 to give the 
dehydroamino acid in good yield. 
MeO
O
NH3Cl
OH
MeO
O
NH
Fmoc
4
1. FmocCl, TEA, DCM, 100%
2. MsCl, TEA, DCM, 79%
 
Scheme 5: Preparation of the dienophile 
 
 Dehydroamino acids such as 4 can undergo DA reactions under various conditions.51,  52
With these facts in mind, it was hoped that a Diels-Alder reaction could be accomplished under 
similar conditions.  However, certain forcing circumstances may be necessary. 
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  Thus, with the two requisite fragments available in a straight-forward manner, a short 
series of DA reactions were attempted between diene 3 and dienophile 4 (Table 1). 
N
Ns
CO2Me
NHFmoc
t-BuO2C
N
Ns
t-BuO2C NHFmoc
CO2Me
2
3
4
SOLVENT REAGENTS TEMP(°C) TIME(h) RESULT
Toluene
Toluene
Toluene
Toluene
---
   ---
   ---
TiCl4, Ti(Oi-Pr)4
60
110
80
RT
24
6
6
6
NR
decomposition
decomposition
decomposition  
Table 1: Attempted Diels-Alder reactions 
 
 Upon heating of the reaction mixture to any temperature above 60 °C, only 
decomposition of the diene component was observed.  Conversely, at lower temperatures, no 
reaction was detected.  Titanium Lewis Acid activation of the dienophile52 failed to produce any 
cycloadduct, with only decomposition of the diene apparent.  Apparently the HOMO-LUMO 
energy gap was too large to facilitate reaction, so a model reaction was performed to verify that 
the dienamide was indeed a reactive DA diene.  Reaction of the dienamide 3 with methyl 
acrylate, did indeed result in cycloadduct formation (Scheme 6), however only in modest yield 
(44 %).  It was clear by mass spectral and 1H NMR analysis that at least three regio- or 
stereoisomers were formed.  This result is in accord with the work of Cha39 who observed 
reversed regioselectivity and low exo/endo selectivity in DA reactions with carbamate 
derivatives and ethyl acrylate.  Because the objective of this experiment was to test the reactivity 
of the dienamide 3 and not the selectivity of the reaction, no further attempt was made at 
separating or fully characterizing the mixture of cycloadducts 10 and 11.  
17 
 N
Ns
t-BuO2C
3
N
Ns
t-BuO2C
N
Ns
t-BuO2C
CO2Me
60°C
toluene
CO2MeH H CO2Me
+
10 11  
Scheme 6: DA reaction with methyl acrylate 
 
 With this encouraging result it was apparent that a more electron deficient dienophile was 
necessary to undergo DA reaction with dienamide 3.  Therefore a method was needed to 
synthesize a different masked amino acid dienophile.  Because of the positive result seen with 
methyl acrylate, it was expected that a methylene malonate derivative should undergo DA 
reaction just as readily.  Moreover, the malonate can be converted to a protected amino acid 
moiety in just two steps after the DA reaction. 
 Methylene malonates are very useful intermediates for organic synthesis53, however, 
their high instability to anionic polymerization does not allow for easy handling or purification of 
these compounds.  Nonetheless, a one step preparation54 from the Eli Lilly Corporation of a 
methylene Meldrum’s acid precursor was discovered and proved to be a very efficient method of 
generating an electron deficient dienophile for DA reactions (Scheme 7). 
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Scheme 7: Synthesis of methylene Meldrum’s Acid 
 
Aqueous formaldehyde was added to Meldrum’s acid 12, dissolved in pyridine, to form the 
stable solid betaine compound 13.  Treatment with mild acid in situ generated the methylene 
Meldrum’s acid dienophile 14.  Dienamide 3 rapidly underwent DA reaction (Scheme 8) with 
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 methylene Meldrum’s acid 14 at room temperature to give cycloadducts 15a,b as a 1:1 mixture 
of diastereomers. 
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Scheme 8: Diels-Alder reaction with methylene Meldrum’s acid 
 
No directing effect was observed from the t-butyl ester of the diene to give any diastereofacial 
selectivity.  Additionally, lowering the reaction temperature to -80 °C failed to change the 
diastereomeric ratio.  This lack of stereoselectivity may be due to a stepwise mechanism rather 
than a concerted route. 
 Separation of the diastereomers 15a,b was accomplished on activated silica gel using a 
95:5 benzene:ether mobile phase, however the diastereomers surprisingly isomerized, quite 
readily, to the thermodynamically more stable tetra-substituted enamide, such as compound 20 
(Scheme 11).  The structure was verified by 1H NMR, 1H-1H homodecoupling, and mass spectral 
analysis.  Disappearance of the amino acid α-protons (4.37, 4.63 ppm) of diastereomers 15a,b 
and appearance of a single α-proton signal (4.62 ppm) suggested an isomerization of the olefin to 
the ring junction of the hydroindole.  It was discovered that similar isomerizations were observed 
by Mori44 and Merck Laboratories.55  As a result, the diastereomers were carried on through the 
synthesis as a mixture (Scheme 9).  
 Quantitative ring opening of the Meldrum’s acid ring of 15a,b was accomplished56 by 
treatment with sodium methoxide at low temperature.  When the reaction was conducted at room 
temperature, decarboxylation accompanied to a great extent, resulting in low yield.  However, 
decarboxylation could be avoided completely at -78 °C.  The result was a mixture of four 
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 diastereomers of the mono methyl ester 16a,b,c,d visible by NMR.  A two step one pot Curtius 
rearrangement/Fmoc protection57 provided enamide 17 in low yield presumably due to the 
inefficiency of the trapping of the isocyanate intermediate by 9-fluorenemethanol.58  Increasing 
the amount of copper (I) chloride catalyst did not affect the yield to any great extent.  Alternative 
methods59,  60 are available to optimize this reaction. 
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Scheme 9: Completion of the hydroindole monomer synthesis 
 
 Reduction of enamide61 17 was accomplished with triethyl silane in trifluoroacetic acid 
to give the hydroindole molecular building block 1 (Scheme 9).  Disappointingly, a large amount 
of unexpected ring cleaved product was discovered by LC-MS analysis.  The iminium ion 
intermediate was prone to attack by water.  Interestingly, a similar hydrolysis was observed by 
Witulski43 on a separate enamide substrate containing a more acid labile allylic alcohol (Scheme 
10). 
N
H
OHMeO2C
Ts
NH
MeO2C
Ts
O
H+
CHCl3, 78%
2:1 mixture
of diastereomers 
Scheme 10: Witulski’s ring cleavage and rearrangement 
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 Based on these results, an attempt to remove the enamide olefin at an earlier stage was 
made.  Ionic hydrogenation conditions were applied to DA adduct 15, but an analogous partial 
ring cleavage reaction, identical to that of compound 17, was observed to yield 18.  This was 
verified by the appearance of two characteristic sulfonamide nitrogen proton doublets (6.11, 6.22 
ppm) and two diastereomeric α-proton ddd signals (4.03, 4.22 ppm).  The iminium ion 
intermediate 19 (Scheme 11) was prone not only to nucleophilic attack, but also α-elimination of 
a proton allowing ring opening or isomerization of the enamide olefin. 
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Scheme 11: Iminium ion transformations 
 
2.2.3. Conclusions 
It has been proven that a chiral amino acid diene, synthesized from (R)-allyl glycine, can 
undergo a DA reaction with a sufficiently electron deficient, masked amino acid dienophile to 
generate a monomer for potential use in constructing rigidified oligomers.  The hydroindole 
molecular building block 1 was synthesized as a mixture of stereoisomers, however, due to the 
propensity of the enamide intermediate to isomerize and the acid sensitivity of the molecular 
building block, partial ring cleavage occurred.  The instability of the enamide olefin required that 
it be absent to produce a useful hydroindole monomer.  It was now apparent that this monomer 
will not be accessible by a Diels-Alder pathway due to the resultant unstable cyclohexene ring.  
An alternate path must be explored. 
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 2.3. Azabicyclo[2.2.2]octane Monomer 
 
2.3.1. Retrosynthetic Analysis 
The azabicyclo[2.2.2]octane ring structure 21 (Scheme 12) has been synthesized by the 
Diels-Alder method by numerous researchers.41,42,62  The ring structure itself is a very rigid three 
dimensional molecule that has great potential for use in rigidified oligomers.  Complications in 
the synthesis of an azabicyclo[2.2.2]octane monomer (2ABCO) are invoked by the need to 
incorporate two amino acid functionalities into the ring system.  1,2-dihydropyridine 22 
derivatives can act as sufficiently good DA dienes41,62 for the construction of an 2ABCO ring 
system both in an inter- and intramolecular fashion.  Here it was hoped that a similar chiral 1,2-
dihydropyridine would undergo DA reaction with a dehydroamino acid dienophile, yielding an 
appropriate monomer for use in oligomer synthesis. 
N
P
R1
R2
N
R3
R3
P
R2R1
+
21 22 23  
Scheme 12: Construction of 2ABCO ring system via DA reaction 
 
 Synthesis of the dienophilic dehydroalanine was already accomplished (vide infra) thus, 
only work toward construction of the 1,2-dihydropyridine moiety will be presented here.  
Comins63 has devised a very efficient method of synthesizing chiral dihydropyridines via 
enantioselective Grignard addition into a chiral acyl pyridinium salt followed by reduction of the 
resultant dihydropyridone and elimination.  Streith64 then adapted the method of Comins to the 
development of a simplified procedure for the synthesis of dihydropyridones that does not 
require an overly expensive chiral auxiliary or installation/deprotection of bulky silyl groups.  
22 
 Here, the method of Streith (Scheme 13) was used to attempt the Grignard addition of a masked 
carboxylic acid derivative 27 into a chiral 4-methoxy acyl pyridinium salt 26. 
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Scheme 13: Retrosynthesis of chiral 1,2-dihydropyridine 
 
The requisite dihydropyridine 24 could then be obtained by N-protection and trapping of 
the enolate of dihydropyridone 25.  The method of asymmetric induction for this Grignard 
reaction, in this case, was believed to originate from chelation controlled Grignard addition into 
the 2-position of the chiral pyridinium salt.  Streith proposed the following model (Figure 10) 
displaying the minimum energy conformation of the pyridinium complex where a dihdedral 
angle of 60° exists between the urea carbonyl and the pyridine ring.  The magnesium of the 
Grignard chelates to the urea carbonyl of the chiral auxiliary, holding the Grignard above the two 
position of the pyridine ring, allowing re-face attack to the less hindered β-side. 
N
O
N
O
CO2Me
O
re-attack
-sideβ
 
Figure 10: Streith’s proposed model for asymmetric induction 
 
2.3.2. Results and Discussion 
The chiral pyridinium salt 26 was prepared via literature conditions65 with commercially 
available 4-methoxy pyridine and the Seebach auxiliary 3066, available from the condensation of 
23 
 serine methyl ester hydrochloride with pivaldehyde 28 followed by acylation with a solution of 
phosgene (Scheme 14).  The condensation reaction of pivaldehyde with serine methyl ester 
provided the oxazolidine as a ca. 1:1 mixture of diastereomers, visible by NMR.  Acylation with 
phosgene and crystallization led to the diastereomerically pure chiral auxiliary 30 in 56% yield 
over two steps.  Treatment of 30 with 4-methoxypyridine in the presence of sodium iodide led to 
gradual formation of the pyridinium ion after 5 days, the progress of which, was followed by 
NMR. 
N
O
CO2Me
O
N
OMe
XN
O
CO2Me
O
Cl
HN
O
CO2Me
O
H
(L)-Serine-OMe HCl
TEA, benzene, reflux
28 29 30 26
phosgene, TEA
DCM, -15 C, 
56%, 2 steps
4-MeO-pyr, anh. NaI, 
toluene, 5 days
°
 
Scheme 14: Preparation of Seebach’s auxiliary 
 
 A suitable masked carboxylic acid Grignard was found in benzyloxymethyl magnesium 
chloride 31.  After addition to the substrate, subsequent debenzylation and oxidation of the 
resultant alcohol to the carboxylic acid would afford the amino acid moiety.  Preparation of the 
Grignard67, however, proved nontrivial.  The reproducibility of Grignard formation was poor due 
to its great instability.  Grignard formation took place, nonetheless, at 0 °C in the presence of 
magnesium metal and freshly sublimed mercury (II) chloride in THF.  Great care was taken in 
preparation of materials and purification of reagents, but it appeared side reactions repeatedly 
prevented addition to the pyridinium salt, as only benzyl alcohol and chiral auxiliary were 
recovered from the reaction mixture.  As a result, Streith’s method was tested (Scheme 15) by 
addition of methyl magnesium bromide into his chiral pyridinium salt 26.  The reaction 
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 proceeded in moderate yield (48 %) giving the chiral methylated dihydropyridone 32, with 
spectral data matching the literature values64. 
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Scheme 15: Grignard reactions 
 
 With the knowledge that addition into the pyridinium salt was possible, another masked 
carboxylic acid Grignard reagent was prepared in hope of generating the amino acid containing 
dihydropyridine.  2-Thiophene magnesium bromide 33 was prepared via a published 
procedure.68  The thiophene moiety can be oxidized readily69 to the carboxylic acid by treatment 
with sodium periodate and ruthenium trichloride. 
 Upon addition of the thiophene Grignard and subsequent hydrolysis with 10% HCl, 
compound 34 was isolated in 25 % yield as a single product of the reaction.  Ring opening most 
likely occurred during the hydrolysis of the intermediate methyl enol ether with acid.  Perhaps 
the ring opening is favored due to the extended conjugation generated by the bis-enone with the 
aromatic thiophene.  With repeatedly low yielding and/or failed attempts at accomplishing the 
desired Grignard reaction, it was decided that an alternate route to the 1,2-dihydropyridine DA 
diene was needed. 
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 Entry into the 1,2-dihydropyridine moiety might be accomplished through the use of a 
ruthenium catalyzed ring-closing metathesis (RCM) strategy.   
N
P
CO2R N
P
CO2R N
P
CO2R H2N CO2H
36 37 635  
Scheme 16: Alternative retrosynthesis of 1,2-dihydropyridine 
 
The target diene 35 could be obtained from monoene 36 by a bromination/double 
dehydrobromination sequence.70  The requisite monoene is derived from N-allylated-(R)-allyl 
glycine 37 through an RCM71 reaction.  The unnatural amino acid precursor 6 is then prepared 
from known chemistry (vide infra).  
 The synthesis began (Scheme 17) from Ns-protected (R)-allyl glycine 38.  PMB 
protection72 of the carboxyl functionality was accomplished under biphasic reaction conditions 
to yield the fully protected allyl glycine 39 in excellent yield.  Compound 39 then underwent 
allylation of the sulfonamide nitrogen73 in DMF to give the bis-allyl amino acid 40 which then 
was subjected to ring closing metathesis conditions71 to afford monoene 41 in 82 % yield.  
Bromination70 of the monoene was done by dropwise addition of liquid bromine at 0 °C, yielding 
the dibromide 42 as one diastereomer, the absolute configuration of which, was determined by 
the relative coupling constants of the ring protons, revealing that both bromines occupy axial 
positions on the piperidine ring. 
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Scheme 17: Alternate synthesis of 1,2-dihydropyridine 
 
 Double dehydrobromination was attempted using modified Raucher conditions70 with 
ethyl aluminum dichloride in dichloromethane at room temperature. These nonbasic conditions 
would allow dehydrobromination without epimerization of the amino acid α-proton, however no 
elimination was observed after 24 hours.  More polar solvents such as HMPA and DMPU were 
also tried, but no reaction was observed.  The PMB ester was removed and various non-
nucleophilic bases such as triethylamine and DBU were also investigated, along with aqueous 
solutions of KOH, but to no avail.  Even in refluxing KOH, no product was obtained.  Finally, a 
set of conditions was found that did result in dehydrobromination, however over-elimination 
accompanied, resulting in pyridine formation with loss of the nosyl protecting group.  After 
exhaustively exploring various conditions for this reaction it was decided, disappointingly so, 
that yet another approach to the 1,2-dihydropyridine was necessary. 
 Galvez74 and coworkers have developed a very convergent method (Scheme 18) to chiral 
dihydropyridone compound 46 through Lewis acid catalyzed tandem Mannich-Michael reaction 
of chiral imine 45, derived from (R)-glyceraldehyde, with Danishefsky’s diene 44.  This enone 
46 could then be converted to the corresponding dihydropyridine 47 by enolization and trapping 
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 with a trialkylsilyl halide.  The reaction was repeated here to give the desired compound 46 in 56 
% yield as one diastereomer. 
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Scheme 18: Aza Diels-Alder reaction 
 
 With enaminone 46 in hand, the desired dihydropyridine was now accessible in just one 
step by silyl enol ether formation.  The methods of Rawal75 and Comins62 were tested, however, 
no reaction was observed.  Silyl enol ether formation was rather difficult and, as of yet, 
unsuccessful.  
 
2.3.3. Conclusions 
The 1,2-dihydropyridine moiety can be difficult to synthesize when containing a chiral 
amino acid subunit.  Three approaches to this molecule were attempted with limited success.  If 
further methods can be discovered to complete the synthesis of the requisite DA diene, 
subsequent Diels-Alder testing could begin.  The 2-azabicyclo[2.2.2]octane bis-amino acid 
monomer is still considered a valuable molecular building block for use in our rigidified 
oligomers.  It is hoped that further work in this area will be fruitful in the future. 
2.4. Experimental Section 
General: Tetrahydrofuran and diethyl ether were distilled from Na/benzophenone ketyl.  
Acetonitrile and dichloromethane were distilled from CaH2.  Pyridine and triethylamine were 
dried by storage over KOH pellets.  All other reagents were used as received unless otherwise 
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 noted.  Column chromatography was performed using ICN Silitech 32-63 D (60 A) grade silica 
gel.  Thin layer chromatography was performed using plates from EM Science (silica gel 60 F254 
/250μm thickness).  NMR spectroscopy was performed using Bruker 300 and 500 MHz 
instruments.  IR spectra were obtained on a Nicolet FT-IR.  Mass Spectra were done using a VG 
high resolution mass spectrometer.  HPLC analysis was performed using a Hewlett Packard 
Series 1050 HPLC.  LCMS analysis was performed using a Hewlett Packard Series 1100 LC-
MS.  Chemical shifts were reported in parts per million downfield relative to trimethylsilane and 
categorized as s = singlet, d = doublet, dd = double doublet, ddd = doublet of doublet of doublet, 
etc., t = triplet, q = quartet, m = multiplet.  All reactions were carried out under inert atmosphere 
of nitrogen or argon in oven or flamed dried glassware unless otherwise noted.   
(2R)-2-(2-nitrobenzenesulfonyl amino)-pent-4-enoic acid (7, 38). 
(R)-allyl glycine (5.10 g, 44.3 mmol) was ground to a fine powder using a mortar and pestle and 
suspended in dry DCM in a flame-dried 250 mL round bottom flask under N2 atmosphere.  
Chlorotrimethylsilane (11.2 mL, 88.6 mmol) was added and the mixture refluxed for 1 h.  The 
reaction flask was then cooled in an ice bath and N,N-diisopropyl ethyl amine (13.4 mL, 76.7 
mmol) added dropwise followed by 2-nitrobenzenesulfonyl chloride (6.50 g, 29.5 mmol) in one 
portion.  The mixture was stirred on ice for 20 min and then warmed to room temperature.  After 
stirring for two additional hours, the reaction mixture was concentrated in vacuo and distributed 
between 100 mL diethyl ether and 100 mL of 2.5 % aqueous NaHCO3.  The phases were 
separated and the aqueous portion extracted twice with 20 mL portions of ether.  The organic 
layers were washed with water (2 x 30 mL) and the combined aqueous layers were then acidified 
to pH 2 with 1 M aqueous HCl.  The cloudy aqueous layer was then further extracted with 
EtOAc (3 x 40 mL).  The organic layers were dried over Na2SO4, filtered and concentrated in 
29 
 vacuo to yield 8.30 g (93 %) of 7 as a yellow oil from which EtOAc was difficult to remove.  IR 
(neat): 3317, 1727, 1540, 1355, 1169 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.07-8.10 (m, 1H), 
7.90-7.94 (m, 1H), 7.74-7.77 (m, 2H), 6.05 (d, 1H, J = 8.5 Hz), 5.63 (dddd, 1H, J = 17.0, 9.7, 
7.1, 7.1 Hz), 5.16 (dd, 1H, J = 17.1, 1.4 Hz), 5.15 (d, 1H, J = 11.4 Hz), 4.30 (ddd, 1H, J = 11.6, 
8.5, 5.9 Hz), 2.57 (br t, 2H, J = 6.0 Hz); 13C NMR (75 MHz, CDCl3): δ 174.9, 147.7, 134.5, 
133.9, 133.1, 130.7, 130.5, 125.7, 120.8, 55.8, 37.16; HR-MS (EI) calcd for C11H12N2O6S (M+) 
300.0416, found 300.0416. 
(2R)-2-(2-nitrobenzenesulfonyl amino)-pent-4-enoic acid tert-butyl ester (8). 
To an oven dried 250 mL round-bottom flask with a magnetic stirring bar, was added (R)-2-
nitrobenzenesulfonyl protected allyl glycine 7 (8.00 g, 26.6 mmol) in dry DCM (80 mL) under 
N2 atmosphere.  Conc. sulfuric acid (266 μL) was then added and the reaction flask placed on 
ice.  Isobutylene gas was bubbled through the solution until the point of saturation (when the 
volume of solvent increased by half).  The reaction mixture was then warmed to room 
temperature and stirred for three hours.  Sufficient, solid anhydrous Na2CO3 (approx. 1 g) was 
added to the mixture to neutralize the acid (verified by pH paper).  The mixture was poured into 
a 250 mL separatory funnel containing 50 mL of water.  The phases were separated and the 
organic phase washed once with a 20 mL portion of water.  The organic layer was dried over 
Na2SO4, filtered and concentrated by rotary evaporation to yield 8 (8.70 g, 92 %) as a yellow oil.  
The oil was recrystallized in diethyl ether to yield pure 8 (7.30 g, 77 %, mp 80.0-80.1 °C) as a 
highly crystalline, yellow solid.  The mother liquor was concentrated and dissolved in hot ether 
to yield a second crop (0.80 g, 8 %) for a total yield of 8.1 g (85 %);  IR(neat): 3295, 1707, 1643, 
1592, 1542, 1343, 1311, 1261, 1145, 856, 742 cm-1;  1H NMR (300 MHz, CDCl3): δ 8.07-8.10 
(m, 1H),  7.90-7.93 (m, 1H), 7.70-7.73 (m, 2H), 6.10 (1H, d, J = 9.1 Hz), 5.71 (dddd, 1H, J = 
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 17.1, 9.2, 7.0, 7.0 Hz), 5.16 (dd, 1H, J = 11.2, 0.9 Hz), 5.15 (dd, 1H, J = 15.9, 0.9 Hz), 4.17 (ddd, 
1H, J = 11.6, 9.0, 5.8 Hz), 2.55 (dd, 1H, J = 5.9, 5.9 Hz), 2.55 (dd, 1H, J = 8.0, 8.0 Hz), 1.25 (s, 
9H); 13C NMR (CDCl3, 75 MHz): δ 169.3, 147.7, 134.6, 133.4, 132.8, 131.2, 130.4, 125.5, 
119.8, 82.7, 56.6, 37.7, 27.7; HR-MS (EI) calcd for C12H15N2O6S (M-C3H5) 315.0651, found 
315.0639. 
(2R)-2-[ethynyl-(2-nitro-benzenesulfonyl)-amino]-pent-4-enoic acid tert-butyl ester (9). 
To a dry, 100 mL, round-bottom flask, under N2, was added 2.50 g (7.00 mmol) of 8 and 
anhydrous DMF (21 mL).  Solid anhydrous Cs2CO3 (3.40 g, 10.5 mmol) was added in one 
portion to the clear slightly yellow solution.  The mixture was allowed to stir for approximately 
20 min, at which time the solution turned a turbid bright yellow color.  The ethynyl(phenyl) 
iodonium tetrafluoroborate (2.80 g, 9.10 mmol) was added in 6 portions over a period of 15 min, 
after which the solution turned a dark brown color.  After stirring for three more hours at room 
temperature, the bulk of the DMF was removed by rotary evaporation at 80 °C.  The resulting 
solution was partitioned between sat. aq. NH4Cl and DCM (20 mL each).  The organic layer was 
removed and the aqueous layer extracted with three 30 mL portions of DCM.  The combined 
organic layers were washed once with 1 M HCl (30 mL) and three times with sat. aq. NaCl.  The 
organic layers were dried, filtered and concentrated in vacuo.  The resulting yellow oil was 
purified by flash chromatography (1:2 EtOAc:hexane) to yield 2.10 g of 9 as an oil that solidified 
under high vacuum (1 mmHg).  The solid was recrystallized in diethyl ether/hexanes to yield 
1.90 g (74 %, mp 77.0-78.0°C) as rod-like crystals.  IR(neat): 3293, 2136, 1742 cm-1; 1H 
NMR(300 MHz, CDCl3): δ 8.22-8.25 (m, 1H), 7.75-7.79 (m, 2H), 7.66-7.69 (m, 1H), 5.81 
(dddd, 1H, J = 17.7, 10.0, 7.7, 6.1 Hz), 7.24 (dd, 1H, J = 17.0, 1.4 Hz), 5.14 (dd, 1H, J = 9.9, 0.8, 
Hz), 4.60 (dd, 1H, J = 10.3, 4.7 Hz), 2.90 (s, 1H), 2.75-2.85 (m, 1H), 2.58-2.71 (m, 1H), 1.36 (s, 
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 9H); 13C NMR (CDCl3, 75 MHz): δ 167.4, 147.8, 134.5, 132.2, 132.0, 131.8, 131.0, 124.1, 
119.2, 82.8, 72.2, 62.0, 61.5, 34.3, 27.7; HR-MS (EI) calcd for C12H11N2O4S (M-C5H9O2) 
279.0440, found 279.0447. 
(2R)-1-(2-Nitro-benzenesulfonyl)-5-vinyl-2,3-dihydro-1H-pyrrole-2-carboxylic acid tert-
butyl ester (3). 
The alkynamide 9 (690 mg, 1.80 mmol) was dissolved in anh. toluene (90 mL) in a 250 mL 
Schlenk flask.  To the solution was also added Grubbs second generation catalyst (76 mg, 0.09 
mmol, 5 mol %).  The solvent was then degassed by the freeze-pump-thaw method.  Ethylene 
gas was then bubbled through the solution and the mixture heated to 80 °C for 15 min.  The 
solution was cooled to room temperature and a few drops of ethyl vinyl ether added to the flask.  
The toluene was removed in vacuo and the residue was chromatographed on silica gel (1:2 
EtOAc:hexane, Rf = 0.30).  The resulting brown oil was recrystallized from EtOAc/hex to yield 
596 mg (86 %) of product as yellow florets.  IR (neat): 3096, 1741, 1629, 1547, 1167, 990, 852 
cm-1; 1H NMR (300 MHz, CDCl3): δ 8.02-8.06 (m, 1H), 7.61-7.74 (m, 3H), 6.52 (ddd, 1H, J = 
17.4, 11.0, 1.0 Hz), 5.55 (d, 1H, J = 17.4 Hz), 5.35 (dd, 1H, J = 2.5, 2.5 Hz), 5.23 (d, 1H, J = 
11.0 Hz), 4.92 (dd, 1H, J = 10.39, 2.90 Hz), 2.90 (m, 1H), 2.62 (m, 1H), 1.48 (s, 9H); 13C NMR 
(75 MHz, CDCl3): δ 170.0, 148.2, 141.4, 133.8, 132.4, 131.7, 131.3, 127.3, 124.0, 118.6, 110.7, 
82.3, 63.4, 32.3, 27.8; HR-MS (EI) calcd for C17H20N2O6S (M+) 380.1042, found 380.1052. 
2-(9H-Fluoren-9-ylmethoxycarbonylamino)-acrylic acid methyl ester (4). 
Commercially available serine methyl ester hydrochloride (2.00 g, 12.8 mmol) was suspended in 
dry DCM and triethylamine (3.50 mL, 25.7 mmol) was added.  The now homogeneous solution 
was cooled on ice and 9-fluorenylmethyl chloroformate (4.00 g, 15.4 mmol) was added in one 
portion.  The reaction was warmed to room temperature and allowed to stir for one hour.  The 
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 reaction mixture was then quenched with sat. aq. NaHCO3 and poured into water.  The mixture 
was extracted three times with DCM, dried (Na2SO4), filtered and concentrated to yield crude 
Fmoc-Ser-OMe (4.40 g, 100 %).  1H NMR (300 MHz, CDCl3): δ 7.78 (m, 2H), 7.62 (m, 2H), 
7.42 (m, 2H), 7.33 (m, 2H), 5.70 (d, 1H, J = 7.6 Hz), 4.47 (m, 1H) 4.44 (d, 2H, J = 6.8 Hz), 4.24 
(t, 1H, J = 6.7 Hz), 3.98 (m, 2H), 3.81 (s, 3H), 2.57 (br s, 1H) in addition to minor impurities.  
Crude Fmoc-Ser-OMe (4.40 g, 12.8 mmol) was dissolved in DCM and cooled to 0 °C and mesyl 
chloride (1.00 mL, 14.1 mmol) added dropwise.  The mixture was stirred for 10 min and 
triethylamine (3.90 mL, 28.2 mmol) was added in one portion.  The reaction was allowed to 
warm to room temperature overnight.  The reaction was diluted with DCM, washed with sat. aq. 
NH4Cl, NaHCO3, and brine.  The organic layer was dried and concentrated.  The product can be 
isolated by column chromatography (15 % EtOAc:hexane) or by precipitation in MeOH 
(although the product must be further dried by this method) to yield 3.30 g (79 %) of pure 4 as a 
fluffy white powder.  IR (neat): 1715, 1636 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.78 (m, 2H), 
7.61 (m, 2H), 7.42 (m, 2H), 7.33 (m, 2H), 6.24 (s(br), 1H), 5.81 (s, 1H), 4.46 (d, 2H, J = 6.9 Hz), 
4.26 (t, 1H, J = 6.8 Hz), 3.87 (s, 3H);  13C NMR (75 MHz, CDCl3): δ 164.2, 153.1, 143.6, 141.3, 
130.8, 127.8, 127.1, 124.9, 120.0, 67.1, 53.0, 46.9.  HR-MS (EI) calcd for C19H17NO4 (M+) 
323.1158, found 323.1149. 
Diels-Alder Reaction of Diene (3) with Methyl Acrylate; (10, 11). 
The diene 3 (20 mg, 0.05 mmol) was dissolved in dry toluene (160 μL) and methyl acrylate (24 
μL, 0.26 mmol) was added.  The mixture was stirred at 60 °C for 24 h.  The solvent was removed 
by rotary evaporation and the residue was purified by preparative TLC (1:1 EtOAc:hexane).  The 
product band (Rf = 0.52) was soaked in EtOAc, filtered and the solvent removed to yield 11 mg 
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 (44 %) of product as a mixture of multiple diastereomers and regioisomers.  HR-MS (EI) calcd 
for C21H26N2O8S (M+) 466.1410, found 466.1404. 
Diels-Alder Reaction of Diene (3) with Methylene Meldrum’s Acid; (15a,b). 
The diene (1.57 g, 4.10 mmol) was dissolved in dry DCM (20 mL) and acetic acid (589 μL, 8.20 
mmol) was added.  A DCM (20 mL) solution of the dienophile precursor 13 (1.94 g, 8.20 mmol) 
was added dropwise to the stirring solution.  After 10 min, the yellow reaction was washed with 
water and brine then dried and the solvent removed.  The residue was purified on silica gel (30% 
EtOAc:hexane) to yield 1.97 g (89 %) of the Diels-Alder adduct 15 as a 1:1 mixture of 
diastereomers (tr = 24.8, 25.0 min; 5-95 % MeCN:water, 0.1 % TFA).  MS (ES): calcd for 
C24H28N2O10SNa (M+Na), 559.1, found 559.1. 
N-(2-Nitro-benzenesulfonyl)-octahydro-indole-2,5,5-tricarboxylic acid 2-tert-butyl ester 5-
methyl ester (16a,b,c,d). 
Compounds 15a,b (140 mg, 0.28 mmol) were dissolved in THF (14 mL) and cooled to                
-78 °C.  A solution of 25 % NaOMe in MeOH (77.2 μL, 0.300 mmol) was added dropwise over 
20 min.  After 15 min, the solution was quenched with 1 N HCl.  The reaction was poured into a 
separatory funnel and extracted three times with EtOAc.  The combined organic layers were 
washed with brine, dried (Na2SO4), and concentrated to yield the crude half malonic ester in 100 
% yield (132 mg).  Analysis of the mixture by 1H NMR revealed a mixture of four diastereomers 
in nearly equal amounts.  MS (ES): calcd for C22H26N2O10SNa (M+Na) 533.1, found 533.1. 
5-(9H-Fluoren-9-ylmethoxycarbonylamino)-1-(2-nitro-benzenesulfonyl)-octahydro-indole-
2,5-dicarboxylic acid 2-tert-butyl ester 5-methyl ester (17a,b,c,d). 
The free carboxylic acid (132 mg, 0.300 mmol) was dissolved in MeCN (1.4 mL) and 
triethylamine (432 μL, 0.300 mmol) was added.  Diphenylphosphoryl azide (668 μL, 0.300 
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 mmol) was added directly and the mixture refluxed for 30 min.  The reaction was cooled to room 
temperature and 25 mol % CuCl (7.0 mg, 0.07 mmol) was added along with 9-fluorenemethanol 
(166 mg, 0.800 mmol).  The cloudy mixture was stirred for 2 h and quenched with sat. aq. 
NaHCO3.  Extraction three times with EtOAc followed by drying (Na2SO4) and removal of the 
solvent in vacuo led to a brown residue that was purified by column chromatography (1:2 
EtOAc:hexane, Rf = 0.23) to give 55 mg (30 %) of product as a dark yellow oil.  MS (ES): calcd 
for C36H37N3O10S+H (M+1) 704.2, found 704.2. 
5-(9H-Fluoren-9-ylmethoxycarbonylamino)-1-(2-nitro-benzenesulfonyl)-octahydro-indole-
2,5-dicarboxylic acid 5-methyl ester (1a,b,c,d). 
Compound 17 (150 mg, 0.20 mmol) was dissolved in DCM (577 μL) and triethylsilane (109 μL, 
0.700 mmol) added.  The mixture was cooled on ice and trifluoroacetic acid (295 μL, 3.80 
mmol) added dropwise.  The reaction was warmed to room temperature and the solvent removed.  
The resulting brown residue (152 mg, 100 %) was analyzed by LC-MS to reveal the ionic 
hydrogenation product 1 diastereomers (MS (ES) calcd for C32H31N3O10S+H (M+1) 650.1, found 
650.2), and the ring opened product (MS (ES) calcd for C32H31N3O11S+H (M+1) 666.1, found 
666.2). 
(2R,4S)-2-tert-Butyl-3-(3-oxo-5-thiophen-2-yl-penta-1,4-dienylcarbamoyl)-oxazolidine-4-
carboxylic acid methyl ester (34). 
IR (neat): 1749, 1694, 1601, 1253, 1111, 959, 860 cm-1; 1H NMR (300 MHz, CDCl3): δ 11.87, 
(d, 1H, J = 10.2 Hz), 7.73 (d, 1H, J = 15.6 Hz), 7.54 (dd, 1H, J = 10,5, 8.4 Hz), 7.40 (d, 1H, J = 
5.5 Hz), 7.30 (d, 1H, J = 3.5 Hz), 7.07 (dd, 1H, J = 5.0, 3.5 Hz), 6.57 (d, 1H, J = 15.6 Hz), 5.70 
(d, 1H, J = 8.4 Hz), 5.34 (s, 1H), 4.67 (dd, 1H, J = 7.0, 2.6 Hz), 4.59 (dd, 1H, J = 8.7, 2.6 Hz), 
4.01 (dd, 1H, J = 8.7, 7.1 Hz), 3.95 (s, 3H), 0.94 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 190.4, 
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 169.9, 154.9, 140.8, 140.2, 134.5, 131.3, 128.6, 128.2, 125.8, 102.6, 96.9, 67.5, 60.1, 53.0, 37.3, 
25.2; HR-MS (EI) calcd for C15H15N2O5S (M-C4H9) 335.0702, found 335.0701. 
(2R)-2-(2-Nitrobenzenesulfonyl amino)-pent-4-enoic acid 4-methoxybenzyl ester (39). 
Compound 38 (200 mg, 0.6 mmol) was dissolved in DCM (1.4 mL) and sat. aq. NaHCO3 (937 
μL), tetrabutylammonium iodide (269 mg, 0.700 mmol) and 4-methoxybenzyl chloride (91.0 μL, 
0.700 mmol) were added sequentially.  The reaction was stirred for 24 h at room temperature, 
after which, the layers were separated and the aqueous portion extracted with three portions (10 
mL) of DCM.  The combined organic layers were washed with brine, dried, filtered and 
concentrated.  The resulting residue was purified by column chromatography (2:1 
EtOAc:hexane, Rf = 0.48) to give 232.00 mg (98 %) of 39 as a dark yellow oil.  IR (neat): 3318, 
1737, 1612, 827 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.99 (m, 1H), 7.80 (m, 1H), 7.64 (m, 2H), 
7.12 (d, 2H, J = 8.5 Hz), 6.82 (d, 2H, J = 8.6 Hz), 6.16 (d, 1H, J = 8.8 Hz), 5.61 (dddd, 1H, J = 
17.5, 10.3, 7.1, 7.1 Hz), 5.11 (dd, 1H, J = 8.7, 1.6 Hz), 5.09 (dd, 1H, J = 15.2, 1.5 Hz), 4.87 (s, 
2H), 4.28 (ddd, 1H, J = 11.7, 8.9, 5.8 Hz), 3.79 (s, 3H), 2.57 (dd, 1H, J = 6.0, 6.0 Hz), 2.57 (dd, 
1H, J = 6.0, 6.0 Hz); 13C NMR (75 MHz, CDCl3): δ 170.0, 159.6, 147.3, 133.8, 133.5, 132.9, 
132.7, 130.9, 130.1, 126.6, 125.4, 119.9, 113.7, 67.1, 56.0, 55.1, 37.2; HR-MS (EI) calcd for 
C19H20N2O7S (M+) 420.0991, found 420.0980. 
(2R)-2-[Allyl-(2-nitrobenzenesulfonyl) amino] pent-4-enoic acid 4-methoxybenzyl ester (40). 
Dry Cs2CO3 (183 mg, 0.600 mmol) was suspended in anhydrous DMF (1.3 mL) and protected 
amino acid 39 (182 mg, 0.400 mmol) was added, dropwise, as a solution in DMF (0.5 mL).  The 
mixture was cooled on an ice bath and allyl bromide (75.4 μL, 0.800 mmol) was added in one 
portion.  The reaction was warmed to room temperature and stirred an additional 2 h.  The bulk 
of the DMF was removed by rotary evaporation and the resulting residue was partitioned 
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 between sat. aq. NH4Cl and EtOAc.  The aqueous phase was extracted with three, 30 mL 
portions of EtOAc and the combined organic extracts washed with brine and dried.  The solvent 
was then removed and the residue purified by column chromatography (2:1 EtOAc:hexane, Rf = 
0.55) to give 189 mg (95 %) of product 40 as a yellow oil.  IR (neat): 1639 cm-1; 1H NMR (300 
MHz, CDCl3): δ 8.01 (m, 1H), 7.53 (m, 3H), 7.18 (d, 2H, J = 8.7 Hz), 6.86 (d, 2H, J = 8.6 Hz), 
5.81 (m, 2H), 5.14 (m, 4H), 4.96 (d(br), 2H, J = 2.3 Hz), 4.77 (dd, 1H, J = 9.0, 5.9 Hz), 4.06 (m, 
1H), 3.94 (m, 1H), 3.82 (s, 3H), 2.77 (m, 1H), 2.54 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 
170.1, 159.9, 146.8, 139.9, 133.7, 132.3, 132.2, 130.3, 128.5, 125.6, 124.8, 118.7, 115.0, 113.8, 
75.1, 67.3, 61.2, 55.8, 47.5, 34.9; HR-MS (EI) calcd for C22H24N2O7S (M+) 460.1304, found 
460.1282. 
(2R)-1-(2-Nitrobenzenesulfonyl)-1,2,3,6-tetrahydropyridine-2-carboxylic acid 4-
methoxybenzyl ester (41). 
Compound 40 (1.10 g, 2.50 mmol) was dissolved in dry DCM (43 mL) and the mixture was 
degassed three times via the freeze-pump-thaw method.  When the solution had warmed up to 
room temperature Grubbs’ catalyst (209 mg, 0.200 mmol) was quickly added and the mixture 
stirred for 30 min.  The solvent was then removed and the residue purified on silica gel (2:1 
EtOAc:hexane, Rf = 0.38) to give 907 mg (82 %) of 41 as a yellow oil.  IR (neat): 1738, 1617 
cm-1; 1H NMR (300 MHz, CDCl3): δ 8.01 (m, 1H), 7.65 (m, 3H), 7.17 (d, 2H, J = 8.6 Hz), 6.85 
(d, 2H, J = 8.6 Hz), 5.75 (m, 1H), 5.67 (m, 1H), 5.02 (d, 1H, J = 11.9 Hz), 4.94 (m, 1H), 4.91 (d, 
1H, J = 11.9 Hz), 4.03 (m, 2H), 3.82 (s, 3H), 2.69 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 170.4, 
159.8, 147.6, 139.9, 133.5, 131.6, 131.0, 130.1, 127.4, 124.4, 122.9, 122.8, 114.0, 37.7, 55.4, 
53.7, 42.8, 27.8; HR-MS (EI) calcd for C2H20N2O7S (M+) 432.0991, found 432.1013. 
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 (2R,4S,5S)-4,5-Dibromo-1-(2-nitrobenzenesulfonyl) piperidine-2-carboxylic acid 4-
methoxybenzyl ester (42). 
Monoene 41 (651 mg, 1.50 mmol) was dissolved in DCM (21 mL) and cooled to 0 °C.  Liquid 
bromine (93.0 μL, 1.80 mmol) was added dropwise over 10 min.  The reaction was stirred for 2 h 
at 0 °C.  The solvent was evaporated and the residue purified by column chromatography (1:2 
EtOAc:hexane, Rf = 0.57) to give 664 mg (75 %) of pure product 42 as a white foam. IR (neat) 
1740, 1542, 1171, 735 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.06 (m, 1H), 7.66 (m, 3H), 7.25 (d, 
2H, J = 8.5 Hz), 6.86 (d, 2H, J = 8.6 Hz), 5.09 (d, 1H, J = 11.7 Hz), 4.99 (d, 1H, J = 11.7 Hz), 
4.86 (br d, 1H, J = 6.8 Hz), 4.46 (m, 2H), 4.37 (br d, 1H, J = 15.2 Hz), 3.93 (br d, 1H, J = 15.2 
Hz), 3.82 (s, 3H), 3.15 (ddd, 1H, J = 15.5, 6.8, 3.1 Hz), 2.70 (br d, 1H, J = 15.6 Hz); 13C NMR 
(75 MHz, CDCl3): δ 169.7, 159.8, 147.5, 133.6, 133.4, 131.8, 131.2, 130.6, 126.8, 124.5, 113.8, 
67.4, 55.3, 52.6, 47.3, 46.2, 44.8, 28.9; HRMS (EI) calcd for C20H20Br2N2O7S (M+) 589.9358, 
found 589.9345. 
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 3. Synthesis of a Bis-amino Acid that Creates a Sharp Turn 
 
3.1. Introduction 
An alternate approach to the construction of bis-amino acid monomers was necessary 
because the Diels-Alder reaction had not been relatively facile.  Wipf and coworkers76 have 
shown that hydroindole ring systems of cis-fusion can be synthesized stereoselectively through 
the use of a cyclooxidation-rearrangement sequence of Cbz-L-tyrosine (Scheme 19).  The ketone 
functionality can then be elaborated, via a Bucherer-Bergs reaction77, into an amino acid, 
resulting in a rigid bis-amino acid building block. 
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Scheme 19: Wipf’s diastereoselective cyclooxidation 
 
 Several other groups78, ,  79 80 have developed synthetic pathways to the hydroindole ring 
system towards constructing the core of such marine metabolites as Aeruginosin 298A81 and 
Dysinosin A.82  As various methods were available to construct such a ring system, Wipf’s 
process was chosen simply for convenience and facility.   
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  The hydroindole ring acts as a conformationally restricted proline derivative.76  These 
types of compounds project peptide chains into defined regions of space, promoting specific 
turns in peptide folding and bestowing bioactive conformations.83, ,84 85  This inherent quality of 
rigidity represents an important characteristic of a bis-amino acid monomer.   
 The synthesis of a new bis-amino acid hydroindole monomer 1 is presented (Figure 11).  
This monomer is designed to create a tightly curved structure when assembled into oligomers.  
The monomer is demonstrated to couple to the previously developed monomer 229 through pairs 
of amide bonds to create a strongly bent spiro-ladder oligomer.  The structure of oligomer 3 was 
determined in aqueous solution using two-dimensional NMR techniques.  
 
Figure 11: A sharp turn 
 
 The hydroindole monomer was given the name hin(2S4R7R9R).  This abbreviation is 
intended to be used as shorthand for hydroindole (hin) followed by the absolute stereochemistry 
of each chiral center contained in the building block.  Similarly, monomer 2 was named 
pro4(2S4S) because it was derived directly from 4-hydroxyproline (pro4).  Thus, the above 
oligomer 3 is composed of the sequence pro4(2S4S)-hin(2S4R7R9R)-pro4(2S4S)-(L)-tyrosine.   
3.2. Results and Discussion 
The synthesis of monomer 1 used chemistry developed by Wipf and coworkers76,  86 to 
convert (L)-tyrosine into ketone 7 in a five step sequence (Scheme 20). 
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Scheme 20: Synthesis of Wipf’s ketone 
 
The amino group of (L)-tyrosine 4 was protected with the carboxybenzyl (Cbz) group followed 
by exposure to iodobenzene diacetate in basic methanol.  The amino acid underwent an 
oxidative-rearrangement reaction that results in compound 5 as a single diastereomer.  The 
excellent selectivity of this reaction was based upon destabilizing steric interactions between the 
amide oxygen and the methyl ester substituent in the transition state.  Elimination of the tertiary 
mesylate of compound 5 with activated zinc gave 6.  Catalytic hydrogenation of enone 6 
proceeded with good facial selectivity (8:1), leading to the cis-fused hydroindolinone 7. 
 Elaboration of the ketone into a hydantoin mixture through the use of a Bucherer-Bergs 
reaction was first attempted as a possible pathway to an amino acid moiety.  Although the 
reaction proceeded in decent yield (69 %) the resultant mixture of four hydantoin diastereomers 
proved inseparable after exhaustive chromatography/crystallization trials. As a result, an 
additional strategy was employed. 
 Reduction of ketone 7 with the anion of chloroform in tetrahydrofuran at low temperature 
yielded the trichloromethyl carbinol 8 in moderate yield with 10:1 stereoselectivity (Scheme 21).  
Fortunately, the major diastereomer was able to be crystallized from ethyl acetate/hexanes and 
the stereochemistry confirmed using X-ray crystallography (Appendix A).  The degree of 
stereoselectivity is consistent with equatorial attack of the bulky nucleophile to the minimum 
energy conformation of the ketone (Figure 12).87  Bonjoch has shown that the Boc derivative of 
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 the ketone has a strong preference for a conformation that avoids A1,3 strain between the N-
substituent and the C(7) methylene group.88  
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Figure 12: Reduction of ketone 7 
 
 The alcohol 8 was then converted in a single step, with inversion of configuration, to the 
azido methyl ester 9 using a modified Corey-Link89 reaction developed by Dominguez and 
coworkers.90,91  This remarkable reaction is considered to proceed via the gem-dichloro-oxirane 
intermediate shown in Scheme 21. 
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Scheme 21: Synthesis of hin(2S4R7R9R) 
 
 Several methods were evaluated for reduction of azide 9, however, only zinc in acetic 
acid92 provided the amine in any appreciable yield and purity.  Protection of the amine 
intermediate with the phenylfluorenyl (PhF) group was accomplished under basic conditions in 
the presence of the bromide scavenger, lead (II) nitrate, to give 10.93  Other protecting groups 
were similarly experimented with (e.g., Nosyl, Boc, Adoc, Trityl), but only the PhF group 
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 proved successful.  The PhF group is chemically orthogonal to the Cbz protecting group on the 
secondary amine of the building block. The steric bulk provided by the PhF group also shields 
the adjacent methyl ester, allowing for regioselective saponification of the distal methyl ester 
unit, yielding 1.  Monomer 1 contains two orthogonally protected amino acid moieties suitable 
for sequential solid-phase coupling (Scheme 22).   
 The molecular building block 1 was first incorporated into a two-mer structure to test the 
solid phase coupling chemistry on a 4.45 μmol scale utilizing an MBHA resin preloaded with 
Boc-L-tyrosine (Novabiochem).  The resin was deblocked with trifluoroacetic acid, followed by 
two sequential couplings of monomer 1, and finally capped with p-nitrobenzoic acid to give 11.   
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Scheme 22: SPS of (L)-tyrosine-hin(2S4R7R9R)-hin(2S4R7R9R)-p-NO2-benzoate 
 
The roles of the tyrosine and p-nitrobenzyl groups are to provide UV-active chromophores and to 
enhance the lipophilicity of the oligomer to allow C18 reverse-phase purification.  It has been 
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 observed29 previously that oligomers that do not carry lipophilic groups are too water soluble and 
refuse to bind to a C18 reverse-phase column.  Each monomer was activated as the 1-hydroxy-7-
azabenzotriazole (HOAt) ester.94  Quantitative coupling to the previous monomer was achieved 
through double coupling of two equivalents of activated monomer with respect to resin loading.  
Couplings were carried out at room temperature for 90 minutes.  The oligomer was then cleaved 
from the resin with simultaneous removal of all the carboxybenzoyl (Cbz) groups using 
trifluoroacetic/trifluoromethane sulfonic acid mixture to produce 12.   
 Diketopiperazine (DKP) closure was tested, to rigidify the oligomer, by incubation of 12 
in a 20% piperidine solution in dimethylformamide.  Pedroso and coworkers have found that 
piperidine in DMF greatly accelerates DKP formation in peptides.95  Nonetheless, after multiple 
days of incubation, no trace of compound 13 was observed by LC-MS.  As a result, the two-mer 
was resynthesized, containing instead, a hin(2S4R7R9R) monomer with a benzyl ester, replacing 
the methyl ester, as in compound 15 (Scheme 23).  The expected outcome from solid-phase 
synthesis was that upon cleavage from the resin, the resulting flexible oligomer would contain 
both a free secondary amine and a carboxylic acid that could be coupled together via in situ 
activation with a peptide coupling reagent.   
 Compound 15 was synthesized (Scheme 23) in a similar manner to 1, differing only by 
the conditions used in the Corey-Link reaction.  Benzyl alcohol was substituted for methanol as 
the solvent and was removed by Kugelrohr distillation and chromatography.  Although not 
optimized, the synthetic sequence provided enough of compound 15 to test the in situ activation 
strategy.   
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Scheme 23: Synthesis of a hin(2S4R7R9R) derivative 
 
 Two-mer 16 (Table 2) of the sequence (L)-tyrosine-hin(2S4R7R9R)(OBn)-
hin(2S4R7R9R)(OMe) was synthesized as previously (vide infra).  The first hydroindole 
monomer contained a benzyl ester, which upon cleavage from the resin unmasked a free 
carboxylic acid.  The second monomer in the sequence was compound 1, containing a methyl 
ester.  Various peptide coupling reagents were evaluated, but none gave sufficient DKP closed 
product 17.   
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Coupling Reagent                            Solvent/Conditioins                                DKP Product
PyBOP/HOBt                                    DMF/DIPEA                                                 Trace
TFAA                                                     DMF                                                        None
PyBrop                                             DMF/DIPEA                                                  None
 
HATU                                               DMF/DIPEA                                                  None
 
Table 2: In situ coupling trials 
 
 The inability of the DKP to close may be due to a combination of the sterically hindered 
nature of the nucleophile and a strained transition state tetrahedral intermediate.96  Thus, a new 
design rule must be established that no sequence can contain two hin(2S4R7R9R) monomers in a 
row in order to make rigidified oligomers or better conditions are needed to close the DKPs.   
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  Another option is to synthesize hetero-oligomers containing sequences of different 
building blocks.  Ultimately, the most desirable scenario is one in which larger oligomers are 
constructed from a library of diverse monomers.  This will allow greater range in oligomer 
architecture.  Previously a proline based monomer pro4(2S4S) was published that is compatible 
with the hin(2S4R7R9R) coupling chemistry.  Initially two short sequences were synthesized to 
test whether DKP closure would be facile enough to construct rigid hetero-oligomers.  Two-mers 
of the sequence (L)-tyrosine-hin(2S4R7R9R)-pro4(2S4S) 18 and (L)-tyrosine-pro4(2S4S)-
hin(2S4R7R9R) 20 were constructed as previously (Scheme 24).   
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Scheme 24: DKP closure of two-mers 
 
Both compounds 18 and 20 were found to close in 20 % piperidine in DMF at 50 °C.  Reaction 
progress was monitored by LC-MS and was complete after 10 days.  With this result it was 
possible to construct a three-mer and determine its solution structure using NMR spectroscopy.   
 A three-mer of the sequence pro4(2S4S)-hin(2S4R7R9R)-pro4(2S4S)-(L)-tyrosine was 
synthesized on the MBHA·LL HCl resin (Novabiochem) using the previous methods (Scheme 
25).  After the three monomers were coupled, the oligomer was functionalized with an Fmoc-(L)-
tyrosine residue.  An extended, two hour deprotection step was then carried out to remove the N-
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 terminal Fmoc group and to accelerate the attack of the terminal amine on the methyl ester of the 
pro4(2S4S) monomer that precedes it to for diketopiperazine 22.   
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Scheme 25: Synthesis of a three-mer containing a sharp turn 
 
The oligomer was then cleaved from the resin with concomitant cleavage of all the Cbz groups 
and the t-butyl protecting group of the tyrosine side chain, yielding 23.  This flexible oligomer 
was then subjected to DKP annealing conditions as before to provide the rigidified oligomer 3.   
 The molecular mechanics package MOE97 was then used to carry out a stochastic 
conformational search98 of compound 3 to locate the lowest AMBER9499 energy minima in 
vacuo.  The modeled structure of the global energy minimum showed that the molecule was 
strongly bent, with the cyclohexane ring of the central “hin” monomer adopting a chair 
conformation that places the amide nitrogen substituents N18 and N20 in a 1,3-diaxial 
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 arrangement (Figure 13).  This 1,3-diaxial conformation was reasonable because the planes of 
the two amides are parallel to one another and are locked in an extended fused ring system.  The 
first lowest energy minimum that displays a different cyclohexane chair conformation is 2.4 
kcal/mol higher than the global energy minimum, indicating that molecular mechanics predicted 
that this oligomer has a four times greater kT preference for this conformation. 
 
Figure 13: Stereoimage of the lowest energy conformation of 3.  Protons that are correlated in the 2D ROESY 
spectrum are connected with lines (strong, medium, and weak ROESY correlations are colored red, green, 
and blue, respectively). 
 
To test this molecular mechanics prediction the solution structure of the three-mer was 
determined using two dimensional NMR.  The spectra were taken in H2O/D2O/CD3CN 80:10:10 
at a concentration of 4 mM at 4 °C.  Low temperature was utilized to allow the residual solvent 
peak to shift downfield a few ppm so that it did not obscure the α-proton resonances.  The 1H and 
13C resonances were assigned through the interpretation of a collection of 2D spectra including a 
COSY, an HMBC, an HMQC and a ROESY.  The assignment was carried out using the software 
package SPARKY.100  The ROESY spectrum provided 26 cross peaks that correlated non-J-
coupled protons.  The cross-peaks were ranked as strong, medium, and weak on the basis of their 
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 relative intensity.  The ROESY correlations were superimposed on top of the minimum energy 
structure and were completely consistent with the model (Figure 13).  The bent conformation of 
the hin(2S4R7R9R) monomer was supported by eight ROESY correlations, including a web of 
correlations among the proton on N20 and protons on C4, C10, C13, and C14, as well as strong 
correlations between the α-proton on C22 and the proton on C16 (Figure 13).  The 
diketopiperazines between monomers formed shallow boats with their substituents C11 and C23 
occupying pseudoequatorial orientations.  The proline ring-based pro4(2S4S) monomers adopted 
an envelope structure that avoids a 1,3-interaction between the two substituents that are syn to 
one another on the ring (C2 and N8, and C21 and N28).  These conformations are identical to 
what was seen in a previous NMR structure that contained pro4(2S4S).29  The folded-back 
conformation of the tyrosine side chain was also a feature seen in a previous NMR structure and 
was probably due to a hydrophobic interaction between the aryl ring and the methylene of the 
last pro4(2S4S) monomer.29
3.3. Conclusions 
The synthesis of the hin(2S4R7R9R) monomer 1 and its assembly into a heterosequence 
with pro4(2S4S) monomers 2 have been demonstrated.  The solution structure of this monomer 
in the context of a short oligomer, at 4 °C, has been determined to have a strong conformational 
preference to form a tight curve.  Combining this monomer with others to form longer sequences 
should enable the construction of compact, water soluble macromolecules that contain cavities 
with controlled size and shape for a variety of biomimetic and nanotechnology applications. 
3.4. Experimental Section 
General: THF was distilled from Na/benzophenone under N2.  DCM and CHCl3 were distilled 
from CaH2.  Anhydrous methanol was purchased from Aldrich Chemical Company and used 
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 directly.  Pb(NO3)2 was dried by heating in a vacuum oven (95 °C, 1 mm Hg) overnight and 
stored in a sealed container over anhydrous CaCl2. Phenylfluorenyl bromide was prepared 
according to a previously reported procedure (Jamison, T.F., Lubell, W.D., Dener, J.M., Krische, 
M.J., Rapoport, H.  Org. Syn., CV9, 103-106.).  All other reagents were used as received unless 
otherwise noted.  All reactions were carried out in flame-dried or oven-dried glassware under N2 
atmosphere unless otherwise noted.  Column chromatography was performed using ICN Silitech 
32-63 D (60 A) grade silica gel and TLC analysis was performed on EM Science Silica Gel  60 
F254 plates (250 μm thickness).  NMR experiments were performed on either Bruker Avance 300 
MHz or Bruker Avance DRX 500 MHz spectrometers.  Chemical shifts (δ) are reported relative 
to CDCl3 or DMSO-d6 residual solvent peaks, unless otherwise noted.  If possible, rotational 
isomers were resolved by obtaining spectra above 100 °C in DMSO-d6 at the below indicated 
temperatures.  IR spectra were obtained on a Nicolet Avatar E.S.P. 360 FT-IR.  Optical rotations 
were obtained on a Perkin-Elmer 241 polarimeter at the indicated temperatures.  EI-MS was 
performed on a Micromass Autospec high resolution mass spectrometer (CEBE geometry).  
High resolution ESI-MS was performed on a Waters LC/Q-TOF instrument.  HPLC analysis was 
performed on a Hewlett-Packard Series1050 instrument with diode array detector, using a Varian 
Chrompack Microsorb 100 C18 column (5 μm packing, 2.6 mm x 250 mm).  HPLC-MS analysis 
was performed  on a Hewlett-Packard Series 1100 instrument with diode array detector, HP 1100 
MS detector (ESI), using a Waters Xterra MS C18 column (3.5 μm packing, 4.6 mm x 100 mm).  
Analysis of 2D NMR data was performed using Sparky 3, T.D. Goddard and D.G. Kneller, 
University of California, San Fransisco. 
(2S,4R,7S,9R)-1-benzyl 2-methyl 7-(trichloromethyl) octahydro-7-hydroxyindole-1,2-
dicarboxylate (8).   
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 A solution of ketone (7) (2.55 g, 7.70 mmol) in THF (40 mL) was cooled to -78 °C in a dry 
ice/acetone bath and dry CHCl3 (1.55 mL, 19.2 mmol) was added.  A 1 M solution of LHMDS in 
THF (16.9 mL) was added dropwise over a period of 20 min via a syringe pump.  After addition 
was complete, the reaction was stirred for an additional 1 h at -78 °C.  The reaction mixture was 
then poured into a saturated solution of NH4Cl and extracted twice with EtOAc (2 x 50 mL).  
The combined organic fractions were dried (Na2SO4), filtered and the solvent removed in vacuo.  
The remaining residue was then sufficiently purified by flash column chromatography (1:2 
EtOAc:hexanes, loading in 1:1 EtOAc:hexanes).  The resulting foam from purification was then 
recyrstallized from EtOAc/hexanes to yield 1.47 g (43 %) of diastereomerically pure (determined 
by NMR) (8) as small, white granular crystals (mp = 173.8-174.5 °C).  [α]22D = -32.2 (c 0.5, 
DCM); IR (neat) 3344, 1746, 1685, 1419, 1352, 1291, 1203, 1173, 1024, 773 cm-1; 1H NMR 
(300 MHz, 105 °C, DMSO-d6) δ 7.35-7.27 (m, 5H), 5.68 (br s, 1H), 5.13 (br d, J = 12.5 Hz, 1H), 
5.02 (br d, J = 12.5 Hz, 1H), 4.35 (d, J = 8.8 Hz, 1H), 4.22-4.15 (m, 1H), 3.59 (s, 3H), 2.60-2.50 
(m, 1H), 2.47-2.40 (m, 1H), 2.36-2.21 (m, 1H), 2.13-1.90 (m, 2H), 1.86-1.76 (m, 2H), 1.70-1.53 
(m, 2H); 13C NMR (75.4 MHz, CDCl3) (~1:1 mixture of rotamers) δ 172.8, 172.7, 154.3, 153.8, 
136.5, 136.2, 128.4, 128.3, 127.9, 127.8, 109.0, 82.0, 81.9, 67.1, 58.4, 58.3, 55.5, 55.0, 52.3, 
52.1, 33.8, 32.9, 32.5, 32.0, 31.9, 30.7, 25.5, 25.4, 21.0; HR-MS (EI) calculated for 
C19H22Cl3NO5 449.0564, found 449.0569.  
(2S,4R,7R,9R)-1-benzyl-2,7-dimethyl-7-azido octahydroindole-1,2,7-tricarboxylate (9).   
To a solution of alcohol (8) (1.05 g, 2.33 mmol) in 46 mL of anhydrous methanol, was added 
sodium azide (454 mg, 6.99 mmol) and a catalytic amount of 18-crown-6 (10 mg).  DBU (1.75 
mL, 11.6 mmol) was added slowly and the reaction allowed to stir for 22 h.  The reaction 
mixture was diluted with diethyl ether (100 mL), washed with NH4Cl (50 mL), dried (Na2SO4), 
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 filtered and concentrated.  The oily residue was then purified by flash column chromatography 
(1:2 EtOAc:hexanes) to yield azido ester (9) (939 mg, 97 %) as a yellow oil.  [α]21D = -16.9 (c 5, 
DCM); IR (neat) 2105, 1726, 763, 697 cm-1; 1H NMR (300 MHz, 105 °C, DMSO-d6) δ 7.35-
7.28 (m, 5H), 5.10 (d, J = 12.2 Hz, 1H), 5.02 (d, J = 12.2 Hz, 1H), 4.35 (br d, J = 7.8 Hz, 1H), 
4.13-4.05 (m, 1H), 3.76 (br s, 3H), 3.59 (br s, 3H), 2.58-2.50 (m, 1H), 2.42-2.29 (m, 2H), 1.99-
1.92 (m, 1H), 1.85-1.78 (m, 1H), 1.75-1.65 (m, 3H), 1.65-1.58 (m, 1H); 13C NMR (75.4 MHz, 
CDCl3) (~1:1 mixture of rotamers) δ 172.7, 172.4, 170.6, 170.3, 154.0, 153.5, 136.1, 128.2, 
128.1, 127.7, 127.6, 127.6, 127.3, 66.8, 66.6, 64.8, 58.3, 55.1, 54.7, 52.6, 52.5, 52.0, 51.8, 34.2, 
33.6, 33.3, 32.3, 31.0, 27.9, 27.4, 21.5; HR-MS (EI) calculated for C20H24N2O6 (M-N2) 
388.1634, found 388.1635. 
(2S,4R,7R,9R)-1-benzyl-2,7-dimethyl-7-amino octahydroindole-1,2,7-tricarboxylate (9a).  
To a solution of azido ester (9) (2.51 g, 6.03 mmol) in 20 mL of 1:1 AcOH:THF was added 
powdered Zn (250 mg, 10 wt%) in one portion.  The suspension was allowed to stir for 
approximately 45 min.  Evolution of bubbles of N2 gas was observed during this time period.  
(Note: If the reaction was sluggish, an additional 5 wt% of Zn was added to achieve complete 
reaction.)  The Zn was then filtered from the reaction mixture and washed with a copious amount 
(100 mL) of ethyl acetate.  The diluted solution was transferred to a separatory funnel and 
carefully washed several times with saturated NaHCO3.  The combined bicarbonate portions 
were washed twice with fresh portions of EtOAc (20 mL). The combined organic fractions were 
dried (Na2SO4), filtered and the solvent removed in vacuo.  Non- polar impurities were removed 
by adsorption of the residue onto a small plug of silica and elution first with 1:2 EtOAc:hexanes 
followed by 9:1 CHCl3:MeOH.  Finally, the solvent was removed to provide the amine product 
(9a) (1.80 g, 76 %) as a clear, viscous oil.  This compound was used without further purification.  
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 [α]20D = -5.5 (c 0.8, DCM); IR (neat) 3365, 3298, 1705, 1408, 1203, 1122, 1009, 768, 691 cm-1; 
1H NMR (300 MHz, 110 °C, DMSO-d6) (~3:1 mixture of rotamers) δ 7.33-7.27 (m, 5H), 5.11-
5.05 (m, 2H), 4.79 (br s, 2H), 4.32 (br d, J = 8.3 Hz, 1H), 4.25-4.19 (m, 0.25H), 4.19-4.08 (m, 
0.75H), 3.68 (br s, 3H), 3.59 (br s, 2.25H), 3.54 (br s, 0.75H), 2.82 (dd, J = 13.0, 5.6 Hz, 0.25H), 
2.53-2.49 (m, 0.75H), 2.35-2.25 (m, 2H), 1.90-1.75 (m, 2H), 1.72-1.49 (m, 3H), 1.39 (dd, J = 
12.9, 11.1 Hz, 0.75H), 1.23 (dd, J = 12.7, 11.0 Hz, 0.25H); 13C NMR (75.4 MHz, DMSO-d6) 
(~1:1 mixture of rotamers) δ 173.7, 173.5, 172.7, 172.4, 153.5, 152.9, 136.7, 136.6, 128.3, 128.2, 
127.7, 127.2, 126.9, 65.9, 58.1, 57.8, 57.3, 54.9, 54.7, 52.2, 52.0, 51.9, 35.5, 34.5, 33.6, 32.6, 
31.5, 30.5, 29.3, 29.1, 21.3, 21.2; HR-MS (EI) calculated for C20H26N2O6 390.1791, found 
390.1790. 
(2S,4R,7R,9R)-1-benzyl-2,7-dimethyl-7-(9-phenyl-9H-fluoren-9-ylamino) octahydroindole-
1,2,7-tricarboxylate (10).   
To a solution of amine (1.80 g, 4.61 mmol) in dry DCM (10 mL), was added dry Pb(NO3)2 (1.10 
g, 3.32 mmol) and triethylamine (771 μL, 5.53 mmol).  A solution of PhFBr (1.48 g, 4.61 mmol) 
in DCM (5 mL) was added dropwise.  The reaction mixture was allowed to stir for 20 h during 
which time a white cloudy ppt formed.  The reaction mixture was filtered through Celite, the 
solvent removed and the resulting residue purified by flash column chromatography (1:2 
EtOAc:hexanes) to give the PhF-protected product (10) (1.80 g, 62 %) as a white foam.  [α]20D = 
-33.3 (c 0.6, DCM); IR (neat) 3313, 1700, 1413, 1203, 732, 702 cm-1; 1H NMR (300 MHz, 
DMSO-d6) (~2:1 mixture of rotamers) δ 7.84-7.13 (m, 18H), 5.03 (d, J = 13.1 Hz, 0.67H), 4.98 
(d, J = 12.7 Hz, 0.33H), 4.90 (d, J = 12.7 Hz, 0.33H), 4.70 (d, J = 13.1 Hz, 0.67H), 4.22 (br d, J = 
8.9 Hz, 0.33H), 4.13 (br d, J = 8.8 Hz, 0.67H), 3.66-3.55 (m, 1H), 3.55 (s, 2H), 3.47 (s, 1H), 3.09 
(s, 1H), 3.04 (s, 2H), 2.31-1.95 (m, 3H), 1.67-1.62 (m, 2H), 1.51-1.08 (m, 4H), 0.93 (br t, J = 
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 11.7 Hz, 1H); 13C NMR (75.4 MHz, DMSO-d6) (~2:1 mixture of rotamers) δ 173.6, 173.5, 172.7, 
172.3, 153.3, 152.5, 149.9, 149.3, 149.1, 148.4, 147.1, 147.0, 139.7, 139.5, 139.4, 139.1, 136.7, 
136.4, 128.2, 128.0, 127.7, 127.5, 127.2, 126.9, 126.8, 126.7, 126.3, 126.0, 125.3, 120.0, 119.9, 
71.2, 65.8, 65.7, 60.9, 60.7, 57.8, 55.0, 54.8, 51.8, 51.0, 36.8, 33.4, 32.6, 31.5, 31.1, 30.1, 21.0; 
HR-MS (EI) calculated for C37H35N2O4 (M-CO2CH3) 571.2597, found 571.2583. 
(2S,4R,7R,9R)-1-((benzyloxy)carbonyl)-7-(methoxycarbonyl)-7-(9-phenyl-9H-fluoren-9-
ylamino)-octahydro-1H-indole-2-carboxylic acid (1).   
To a solution of (10) (1.80 g, 2.85 mmol) in 6 mL THF was added a solution of LiOH•H2O (533 
mg, 7.12 mmol) in 6 mL of H2O.  The reaction was allowed to stir for 24 h.  It was then 
partitioned between DCM and 1 M HCl and the aqueous portion removed.  The organic layer 
was washed with water (20 mL) and the combined aqueous layer washed twice with DCM (20 
mL).  The combined DCM layers were dried (Na2SO4), filtered and concentrated to yield the 
carboxylic acid (1) (1.50 g, 86 %) as a white foam that was used without further purification.   
[α]20D = -70.4 (c 0.5, DCM); IR (neat) 3062, 1705, 1413, 1347, 1209, 1132, 727, 697 cm-1; 1H 
NMR (300 MHz, DMSO-d6) (~2:1 mixture of rotamers) δ 7.78-7.10 (m, 18H), 5.02 (d, J = 13.1 
Hz, 0.67H), 4.98 (d, J = 12.9 Hz, 0.33H), 4.91 (d, J = 12.9 Hz, 0.33H), 4.69 (d, J = 13.0 Hz, 
0.67H), 4.13 (br d, J = 9.3 Hz, 0.33H), 4.02 (br d, J = 8.8 Hz, 0.67H), 3.64-3.54 (m, 1H), 3.42 (br 
s, 1H), 3.10 (s, 1H), 3.04 (s, 2H), 2.23-2.00 (m, 2H), 1.98-1.94 (m, 1H), 1.66-1.61 (m, 2H), 1.43-
1.05 (m, 4H), 0.91 (br t, J = 11.9 Hz, 1H); 13C NMR (75.4 MHz, DMSO-d6) (~2:1 mixture of 
rotamers) δ 173.7, 173.3, 153.3, 152.7, 150.0, 149.3, 149.2, 148.5, 147.1, 147.0, 139.7, 139.4, 
139.1, 136.9, 136.5, 129.0, 128.2, 128.0, 127.7, 127.4, 126.9, 126.8, 126.3, 125.9, 125.4, 120.0, 
71.2, 65.6, 60.9, 60.7, 57.9, 54.9, 54.7, 51.0, 36.8, 33.4, 31.1, 30.5, 21.0; HR-MS (EI) calculated 
for C36H33N2O4 (M-CO2CH3) 557.2440, found 557.2461. 
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 Synthesis of Oligomers 
General: Solid phase chemistry was performed using a home made manual synthesizer.  Dry 
dichloromethane was obtained from distillation over CaH2.  Anhydrous DMF was purchased 
from Aldrich Chemical Company.  Diisopropylethyl amine (DIPEA) was distilled from 
ninhydrin and potassium hydroxide and stored over molecular sieves (4 A).  O-(7-
azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU) was 
obtained from Acros.  MBHA•LL HCl and MHBA-Y-Boc resins were purchased from 
NovaBiochem.  All solid phase reactions were mixed by bubbling Ar through the reaction vessel 
and continuously kept under Ar atmosphere. 
(L)-tyrosine-hin(2S4R7R9R)-hin(2S4R7R9R) (12) 
  To a 5 mL polypropylene solid phase peptide synthesis (SPPS) reactor vessel was added 
MBHA-Y-Boc Resin (10.6 mg, 4.45 μmol loading).  The resin was swelled for 2 h in dry DMF 
under Ar atmosphere.  Boc deprotection was completed by treatment with a 1:1 mixture of 
TFA:DCM (0.500 mL) for 15 minutes.  Kaiser test was used to verify a free amine on the resin.  
The resin was washed twice with DCM (1 mL), neutralized (20 % DIPEA/DCM, 400 μL) and 
washed twice with DMF (1 mL).   
 
To a 2.2 mL polypropylene micro centrifuge vial were added monomer (1) (5.48 mg, 8.90 μmol) 
and HATU (3.38 mg, 8.90 μmol).  DCM (320 μL) and DMF (80 μL) were added.  DIPEA (3.10 
μL, 17.8 μmol) was added and the solution was vortexed for 1 min to initiate activation of the 
building block.  The homogeneous solution was then added immediately to the solid phase resin.  
The coupling reaction was mixed for 90 min and the solution drained from the resin.  The resin 
was then washed twice with fresh DMF (1 mL) and subjected to a second coupling reaction 
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 under identical conditions.  The resin was washed three times with DMF (1 mL).  The terminal 
PhF protected amine of the building block was deblocked by treatment with 50 % TFA/DCM 
(500 μL) over 15 min.  Release of the PhF chromophore was monitored by UV-vis spectroscopy 
to ensure complete deprotection.  The resin was washed twice with DCM (1 mL), neutralized (20 
% DIPEA/DCM, 400 μL) and washed twice with DMF (1 mL).  The above mentioned coupling 
and deprotection sequence for monomer (1) was performed again under identical conditions.   
 
To a 2.2 mL polypropylene micro centrifuge vial were added 4-nitrobenzoic acid (7.43 mg, 44.5 
μmol) and HATU (16.9 mg, 44.5 μmol).  DCM (320 μL) and DMF (80 μL) were added.  DIPEA 
(15.5 μL, 89.0 μmol) was added and the solution was vortexed for 1 min to initiate activation of 
the building block.  The homogeneous solution was then added immediately to the solid phase 
resin.  The coupling reaction was mixed for 90 min and the solution drained from the resin.  The 
resin was washed twice with DMF, twice with DCM, twice with methanol and twice again with 
DCM.  The oligomer-containing resin 11 was then dried under vacuum at room temperature 
overnight. 
 
Deprotection of the Cbz groups of the oligomer and cleavage of the oligomer from the resin were 
done by treatment with a cleavage solution containing TFA (500 μL), thioanisole (50 μL), ethane 
dithiol (25 μL) and trifluoromethane sulfonic acid (50 μL) for 2.5 h at room temperature with 
magnetic stirring.  The cleavage solution was drained into a centrifuge tube containing an excess 
volume of diethyl ether (35 mL), whereupon the oligomer precipitated as a yellow solid.  The 
resin was washed with an additional portion of TFA (250 μL) and that volume also drained into 
the ether.  The solution was centrifuged (9000 rpm, 30 min), the supernatant decanted and the 
residue washed with an additional portion of ether.  The yellow solid was dried in vacuo and the 
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 product purified by preparative HPLC on a Waters Delta Prep 4000 instrument with photodiode 
array detector (10-35 % MeCN:H2O over 30 min, flow = 43 mL/min, UV detection = 274 nm).  
The product containing fractions were lyophilized to remove the solvent, yielding a fluffy white 
powder 12. HPLC: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV detection = 
274 nm, tR = 13.42 min; LC-MS (ESI) calculated for C38H48N7O11 (M+H) 778.3, found 778.3. 
(2S,4R,7R,9R)-7-(9-Phenyl-9H-fluoren-9-ylamino)-octahydro-indole-1,2,7-tricarboxylic 
acid 1,7-dibenzyl ester (15).   
[α]20D = -41.0 (c 0.6, DCM); IR (neat) 3060, 3027, 1699, 1450, 1413, 1348, 1151, 1119, 735, 694 
cm-1; 1H NMR (300 MHz, DMSO-d6) (~2:1 mixture of rotamers) δ 7.73 (d, 1H, J = 7.4 Hz), 7.62 
(d, 1H, J = 7.5 Hz), 7.53 (d, 1H, J = 7.4 Hz), 7.12-7.36 (m, 20H), 5.01 (d, 1H, J = 13.1 Hz), 4.71 
(d, 1H, J = 13.1 Hz), 4.56 (d, 1H, J = 12.5 Hz), 4.45 (d, 1H, J = 12.5 Hz), 4.12 (br d, 0.40H, J = 
8.9 Hz), 4.00 (br d, 0.60H, J = 8.5 Hz), 3.55-3.65 (m, 1H), 1.90-2.38 (m, 2H), 1.52-1.70 (m, 2H), 
1.20-1.50 (m, 4H), 0.75-0.95 (m, 1H); 13C NMR (75.4 MHz, DMSO-d6) (~2:1 mixture of 
rotamers) δ 173.9, 173.4, 173.3, 153.4, 152.8, 150.0, 149.5, 149.2, 148.6, 147.1, 147.0, 139.7, 
139.5, 139.4, 139.2, 137.0, 136.8, 135.9, 135.8, 128.2, 128.0, 127.8, 127.7, 127.6, 127.5, 127.4, 
127.0, 126.9, 126.8, 126.3, 126.0, 125.4, 120.1, 120.0, 71.3, 65.6, 65.4, 61.1, 60.8, 58.0, 57.8, 
54.9, 54.6, 36.9, 36.7, 33.4, 32.5, 31.7, 31.0, 30.4, 21.0; LC-MS (ESI) calculated for C25H28N2O6 
(M+1-PhF) 452.2, found 452.3. 
(L)-tyrosine-hin(2S4R7R9R)(OH)-hin(2S4R7R9R) (16) 
Compound 16 was synthesized in an identical manner to compound 12.  The synthesis was done 
on an 8.31 μmol scale.  Monomer 15 was coupled to the resin first, followed by monomer 1.  
HPLC: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, tR = 
7.36 min; LC-MS (ESI) calculated for C30H43N6O8 (M+H) 615.3, found 615.3. 
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 (L)-tyrosine-hin(2S4R7R9R)-pro4(2S4S) (18) 
To a 5 mL polypropylene solid phase peptide synthesis (SPPS) reactor vessel was added MBHA-
Y-Boc Resin (24.6 mg, 10.3 μmol loading).  The resin was swelled for 2 h in dry DMF under Ar 
atmosphere.  Boc deprotection was completed by treatment with a 1:1 mixture of TFA:DCM 
(0.500 mL) for 15 minutes.  Kaiser test was used to verify a free amine on the resin.  The resin 
was washed twice with DCM (1 mL), neutralized (20 % DIPEA/DCM, 400 μL) and washed 
twice with DMF (1 mL) 
 
To a 2.2 mL polypropylene micro centrifuge vial were added monomer (1) (12.7 mg, 20.6 μmol) 
and HATU (7.80 mg, 20.6 μmol).  DCM (320 μL) and DMF (80 μL) were added.  DIPEA (7.17 
μL, 41.2 μmol) was added and the solution was vortexed for 1min to initiate activation of the 
building block.  The homogeneous solution was then added immediately to the solid phase resin.  
The coupling reaction was mixed for 90 min and the solution drained from the resin.  The resin 
was then washed twice with fresh DMF (1 mL) and subjected to a second coupling reaction 
under identical conditions.  The resin was washed again with DMF (1 mL).  The terminal PhF 
protected amine of the building block was deblocked by treatment with 50 % TFA/DCM (500 
μL) over 15 min.  Release of the PhF chromophore was monitored by UV-vis spectroscopy to 
ensure complete deprotection.  The resin was washed twice with DCM (1 mL), neutralized (20 % 
DIPEA/DCM, 400 μL) and washed twice with DMF (1 mL).   
 
To a 2.2 mL polypropylene micro centrifuge tube were added monomer (2) (11.2 mg, 20.6 μmol) 
and HATU (7.8 mg, 20.6 μmol).  DCM (320 μL), DMF (80 μL) and DIPEA (7.17 μL, 41.2 
μmol) were added and the solution vortexed for 1 min to initiate activation of the building block.  
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 The homogeneous solution was then immediately pipetted onto the solid phase resin.  The 
coupling reaction was mixed for 90 min and the solution drained from the resin.  The resin was 
then washed twice with fresh DMF (1 mL) and subjected to a second coupling reaction under 
identical conditions.  The resin was washed again with DMF (1 mL).  The terminal Fmoc 
protected amine of the building block was deblocked by treatment with 20 % piperidine/DMF (2 
mL) over 40 min.  UV-visible spectroscopic analysis of the piperidine fluorenyl adduct from the 
deblocking reaction solvent at 301 nm (ε = 7800 M-1cm-1) revealed nearly quantitative coupling, 
relative to initial resin loading.  The resin was washed three times with DMF (1 mL).  The resin 
was washed twice with DMF, twice with DCM, twice with methanol and twice again with DCM.  
The oligomer-containing resin was then dried under vacuum at room temperature overnight. 
 
Deprotection of the Cbz groups of the oligomer and cleavage of the oligomer from the resin were 
done by treatment with a cleavage solution containing TFA (500 μL), thioanisole (50 μL), ethane 
dithiol (25 μL) and trifluoromethane sulfonic acid (50 μL) for 2.5 h at room temperature with 
magnetic stirring.  The cleavage solution was drained into a centrifuge tube containing an excess 
volume of diethyl ether (35 mL), whereupon the oligomer precipitated as a yellow solid.  The 
resin was washed with an additional portion of TFA (250 μL) and that volume also drained into 
the ether.  The solution was centrifuged (9000 rpm, 30 min), the supernatant decanted and the 
residue washed with an additional portion of ether.  The yellow solid 18 was dried in vacuo.  
HPLC: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, tR = 
7.21 min; LC-MS (ESI) calculated for C27H39N6O8 (M+H) 575.2, found 575.2. 
(L)-tyrosine-hin(2S4R7R9R)=pro4(2S4S) (19) 
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 A solution of (18) in approximately 1 mL of 20 % piperidine/DMF was incubated at 50 °C for 10 
days.  The reaction progress was monitored by HPLC-MS.  The reaction mixture was then added 
dropwise to a centrifuge vial containing an excess volume of diethyl ether (35 mL) to precipitate 
the product.  The vial was centrifuged (9000 rpm, 30 min), the supernatant decanted and the 
residue dried under vacuum. HPLC-MS: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 
mL/min, UV detection = 274 nm, tR = 8.31 min, MS (ESI) calculated for C26H35N6O7 (M+H) 
543.2, found 543.2. 
(L)-tyrosine-pro4(2S4S)-hin(2S4R7R9R) (20) 
To a 5 mL polypropylene solid phase peptide synthesis (SPPS) reactor vessel was added MBHA-
Y-Boc Resin (20.0 mg, 8.4 μmol loading).  The resin was swelled for 2 h in dry DMF under Ar 
atmosphere.  Boc deprotection was completed by treatment with a 1:1 mixture of TFA:DCM 
(0.500 mL) for 15 minutes.  Kaiser test was used to verify a free amine on the resin.  The resin 
was washed twice with DCM (1 mL), neutralized (20 % DIPEA/DCM, 400 μL) and washed 
twice with DMF (1 mL). 
 
To a 2.2 mL polypropylene micro centrifuge tube were added monomer (2) (9.10 mg, 16.8 μmol) 
and HATU (6.40 mg, 16.8 μmol).  DCM (320 μL), DMF (80 μL) and DIPEA (5.85 μL, 33.6 
μmol) were added and the solution vortexed for 1 min to initiate activation of the building block.  
The homogeneous solution was then immediately pipetted onto the solid phase resin.  The 
coupling reaction was mixed for 90 min and the solution drained from the resin.  The resin was 
then washed twice with fresh DMF (1 mL) and subjected to a second coupling reaction under 
identical conditions.  The resin was washed again with DMF (1 mL).  The terminal Fmoc 
protected amine of the building block was deblocked by treatment with 20 % piperidine/DMF (2 
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 mL) over 40 min.  UV-visible spectroscopic analysis of the piperidine fluorenyl adduct from the 
deblocking reaction solvent at 301 nm (ε = 7800 M-1cm-1) revealed nearly quantitative coupling, 
relative to initial resin loading.  The resin was washed three times with DMF (1 mL).   
 
To a 2.2 mL polypropylene micro centrifuge vial were added monomer (1) (10.30 mg, 16.8 
μmol) and HATU (6.38 mg, 16.8 μmol).  DCM (320 μL) and DMF (80 μL) were added.  DIPEA 
(5.85 μL, 33.6 μmol) was added and the solution was vortexed for 1min to initiate activation of 
the building block.  The homogeneous solution was then added immediately to the solid phase 
resin.  The coupling reaction was mixed for 90 min and the solution drained from the resin.  The 
resin was then washed twice with fresh DMF (1 mL) and subjected to a second coupling reaction 
under identical conditions.  The resin was washed again with DMF (1 mL).  The terminal PhF 
protected amine of the building block was deblocked by treatment with 50 % TFA/DCM (500 
μL) over 15 min.  Release of the PhF chromophore was monitored by UV-vis spectroscopy to 
ensure complete deprotection.  The resin was washed twice with DCM (1 mL), neutralized (20 % 
DIPEA/DCM, 400 μL) and washed twice with DMF (1 mL).  The resin was washed twice with 
DMF, twice with DCM, twice with methanol and twice again with DCM.  The oligomer-
containing resin was then dried under vacuum at room temperature overnight. 
 
Deprotection of the Cbz groups of the oligomer and cleavage of the oligomer from the resin were 
done by treatment with a cleavage solution containing TFA (500 μL), thioanisole (50 μL), ethane 
dithiol (25 μL) and trifluoromethane sulfonic acid (50 μL) for 2.5 h at room temperature with 
magnetic stirring.  The cleavage solution was drained into a centrifuge tube containing an excess 
volume of diethyl ether (35 mL), whereupon the oligomer precipitated as a yellow solid.  The 
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 resin was washed with an additional portion of TFA (250 μL) and that volume also drained into 
the ether.  The solution was centrifuged (9000 rpm, 30 min), the supernatant decanted and the 
residue washed with an additional portion of ether.  The yellow solid 20 was dried in vacuo.  
HPLC: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, tR = 
7.44 min; LC-MS (ESI) calculated for C27H39N6O8 (M+H) 575.2, found 575.2. 
(L)-tyrosine-pro4(2S4S)=hin(2S4R7R9R)  (21) 
A solution of (20) in approximately 1 mL of 20 % piperidine/DMF was incubated at 50 °C for 10 
days.  The reaction progress was monitored by HPLC-MS.  The reaction mixture was then added 
dropwise to a centrifuge vial containing an excess volume of diethyl ether (35 mL) to precipitate 
the product.  The vial was centrifuged (9000 rpm, 30 min), the supernatant decanted and the 
residue dried under vacuum. HPLC-MS: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 
mL/min, UV detection = 274 nm, tR = 8.00 min, MS (ESI) calculated for C26H35N6O7 (M+H) 
543.2, found 543.2. 
pro4(2S4S)-hin(2S4R7R9R)-pro4(2S4S)=(L)-tyrosine (23) 
To a 5 mL polypropylene solid phase peptide synthesis (SPPS) reactor vessel was added 
MBHA·LL·HCl Resin (26.7 mg, 16.5 μmol loading).  The resin was swelled for 2 h in dry DMF 
under Ar atmosphere.   
 
To a 2.2 mL polypropylene micro centrifuge vial were added monomer (2) (17.9 mg, 33.0 μmol) 
and HATU (12.5 mg, 33.0 μmol).  DCM (320 μL) and DMF (80 μL) were added.  DIPEA (11.5 
μL, 660. μmol) was added and the solution was vortexed for 1 min to initiate activation of the 
building block.  The homogeneous solution was then added immediately to the solid phase resin.  
The coupling reaction was mixed for 90 min and the solution drained from the resin.  The resin 
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 was then washed twice with fresh DMF (1 mL) and subjected to a second coupling reaction 
under identical conditions.  The resin was washed again with DMF (1 mL).  The terminal Fmoc 
protected amine of the building block was deblocked by treatment with 20 % piperidine/DMF (2 
mL) over 40 min.  UV-visible spectroscopic analysis of the piperidine fluorenyl adduct from the 
deblocking reaction solvent at 301 nm (ε = 7800 M-1cm-1) revealed nearly quantitative coupling, 
relative to initial resin loading.  The resin was washed three times with DMF (1 mL). 
 
To a 2.2 mL polypropylene micro centrifuge tube were added monomer (1) (20.3 mg, 33.0 μmol) 
and HATU (12.5 mg, 33.0 μmol).  DCM (320 μL), DMF (80 μL) and DIPEA (11.5 μL, 660 
μmol) were added and the solution vortexed for 1min to initiate activation of the building block.  
The homogeneous solution was then immediately pipetted onto the solid phase resin.  The 
coupling reaction was mixed for 90 min and the solution drained from the resin.  The resin was 
then washed twice with fresh DMF (1 mL) and subjected to a second coupling reaction under 
identical conditions.  The resin was washed again with DMF (1 mL).  The terminal PhF 
protected amine of the building block was deblocked by treatment with 50 % TFA/DCM (500 
μL) over 15 min.  Release of the PhF chromophore was monitored by UV-vis spectroscopy to 
ensure complete deprotection.  The resin was washed twice with DCM (1 mL), neutralized (20 % 
DIPEA/DCM, 400 μL) and washed twice with DMF (1 mL).   
 
The above mentioned coupling and deprotection sequence for monomer (2) was performed again 
under identical conditions.   
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 To a 2.2 mL polypropylene micro centrifuge tube were added N-α-Fmoc-O-tert-butyl-L-tyrosine 
(15.1 mg, 33.0 μmol), HATU (12.5 mg, 33.0 μmol), DMF (80 μL), DCM (320 μL) and DIPEA 
(11.5 μL, 660 μmol).  The mixture was vortexed for 1min to ensure activation of the amino acid 
and then immediately transferred to the resin.  The coupling reaction was mixed for 90 min and 
the solution drained from the beads.  The terminal Fmoc protected amine of the tyrosine was 
deblocked by treatment with 20 % piperidine/DMF (2 mL) over 2 h.  The resin was washed 
twice with DMF, twice with DCM, twice with methanol and twice again with DCM.  The 
oligomer-containing resin was then dried under vacuum at room temperature overnight. 
 
Deprotection of the Cbz groups of the oligomer, tert-butyl protecting group of the tyrosine 
hydroxyl and cleavage of the oligomer from the resin were done by treatment with a cleavage 
solution containing TFA (500 μL), thioanisole (50 μL), ethane dithiol (25 μL) and 
trifluoromethane sulfonic acid (50 μL) for 2.5 h at room temperature with magnetic stirring.  The 
cleavage solution was drained into a centrifuge tube containing an excess volume of diethyl ether 
(35 mL), whereupon the oligomer precipitated as a yellow solid.  The resin was washed with an 
additional portion of TFA (250 μL) and that volume also drained into the ether.  The solution 
was centrifuged (9000 rpm, 30 min), the supernatant decanted and the residue washed with an 
additional portion of ether.  The yellow solid was dried in vacuo and the product purified by 
preparative HPLC on a Waters Delta Prep 4000 instrument with photodiode array detector (10-
35 % MeCN:H2O over 30 min, flow = 43 mL/min, UV detection = 274 nm).  The product 
containing fractions were lyophilized to remove the solvent, yielding a fluffy white powder (~11 
mg). HPLC: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, 
tR = 7.91 min; HR-MS (ESI) calculated for C33H45N8O10 (M+H) 713.3259, found 713.3234. 
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 pro4(2S4S)=hin(2S4R7R9R)=pro4(2S4S)=(L)-tyrosine (3) 
A solution of (23) in approximately 1 mL of 20 % piperidine/DMF was incubated at 48 °C for 10 
days.  The reaction progress was monitored by HPLC-MS.  The reaction mixture was then added 
dropwise to a centrifuge vial containing an excess volume of diethyl ether (35 mL) to precipitate 
the product.  The vial was centrifuged (9000 rpm, 30 min), the supernatant decanted and the 
residue purified by preparative HPLC on a Waters Delta Prep 4000 instrument with photodiode 
array detector (10-35 % MeCN:H2O over 30 min, flow = 43 mL/min, UV detection = 274 nm).  
The product containing fractions were lyophilized to remove the solvent, yielding a fluffy white 
powder (~3 mg). HPLC-MS: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV 
detection = 274 nm, tR = 8.19 min, MS (ESI) calculated for C31H37N8O8 (M+H) 649.2, found 
649.2. 
NMR Sample Preparation 
Approximately 1mg of oligomer (3) was dissolved in 332 μL of 9:1 H2O/D2O, 18 μL of 1 M (9:1 
H2O/D2O) ND4CD3CO2 buffer and 50 μL CD3CN.  The 2-D NMR data was collected at 4 °C.  
The sample was prepared in an advanced micro tube matched with D2O purchased from 
Shigemi, Inc.  Spectra were taken on a Bruker 500 MHz instrument. 
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 4. Towards Macromolecules with Compact Tertiary Structures 
 
4.1. Introduction 
The first step in designing biomimetics34 or functional nano-scale devices35 is to construct 
large molecules with clefts, pockets, loops, and cavities that can bind the small molecule guests 
upon which the device will act.101  The next step involves positioning functional or catalytic 
groups on the concave interior of the macromolecule with sufficient precision in solution to carry 
out a function.102  On the other hand, to achieve such high-affinity and high-specificity 
molecular recognition, it is necessary to control the conformation of the host macromolecule.25  
Thus, controlling structure invariably controls function.  This final chapter examines the first 
step in the creation of protein-like molecular machines, that is, the formation of asymmetric, 
water-soluble macromolecules containing loops and cavities.  Moreover, these molecules will 
have “compact” tertiary structures; a phenomenon not known to synthetic polymers.   
“Primary structure”, as in proteins, is defined here as the sequence of building blocks 
composing the oligomer.  Additionally, “secondary structure” is the conformations of the 
monomer fused ring systems and “tertiary structure” refers to the overall global structure of the 
rigid oligomer.  This “tertiary structure” implies an architecture where the oligomer can fold 
back on itself, having long-range interactions among monomers on opposite sides of the 
sequence. 
4.2. Results and Discussion 
In searching through longer heterooligomer sequences of interest, a particular five-mer 
stood out as a candidate that contained a compact tertiary structure.  Although not functional in 
design, the modeled structure (Figure 14) did possess a loop-like cavity where the two ends of 
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 the sequence were projected over one another in space such that ROESY NMR correlations 
should be seen across the ends of the scaffold.  The sequence of this oligomer was pro4(2S4S)-
hin(2S4R7R9R)-pro4(2S4S)-hin(2S4R7R9R)-pro4(2S4S).  This molecule would be the first 
known example of a synthetic polymer that adopts a compact tertiary structure.   
 
   
        Front View     Top View 
Figure 14: A five-mer loop-containing macromolecule 
 
 The five-mer was constructed using the same chemistry as described previously (Chapter 
3) on the MBHA·LL HCL resin on a 105 μmol scale.  Initially an (L)-tyrosine residue was 
attached to the resin as a lipophilic UV chromophore.  The alternating sequence of pro4(2S4S) 
and hin(2S4R7R9R) monomers was followed by a glycine residue to close a diketopiperazine on 
the leading end, as in 1 (Scheme 26).  Cleavage from the resin with simultaneous removal of the 
Cbz protecting groups yielded crude 2 which was purified via preparative HPLC.   
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Scheme 26: Synthesis of a five-mer 
 
 The cleaved product 2 was then incubated in a 20 % piperidine solution in DMF at 
elevated temperature for 10 days to affect annealing of the oligomer to give 3.  The rigidified 
scaffold was then purified via preparative HPLC and characterized by high resolution 
electrospray mass spectrometry [HR-MS (ESI) calculated for C49H58N13O13 (M+H) 1036.4272, 
found 1036.4301].   Unfortunately, the overall yield for the synthesis of oligomer 3 was <1 %.  
This did not allow for the accumulation of sufficient material for 2-D NMR analysis.  
Subsequent attempts to optimize the overall yield failed to provide enough additional material.  
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 There appeared to be two reasons for the low overall yield, the first being inefficient 
cleavage from the MBHA resin.  The resin was allowed to stir in a trifluoroacetic/ 
trifluoromethane sulfonic acid mixture for approximately two hours.   The solution was drained 
from the resin into a large volume of diethyl ether to precipitate the oligomer and the beads 
washed thoroughly with additional portions of TFA.  Attempts to resubject the resin to another 
cleavage reaction did not provide any more precipitate.  A hydrofluoric acid cleavage was not 
attempted due to lack of proper equipment. 
Several other commercially available resins were tested.  Table 3 shows the resin linkers, 
conditions for the coupling of the first residues to the beads, and cleavage conditions.  All this 
chemistry is outlined in great detail in the Novabiochem catalogue. 
NH2
CH3
NAME STRUCTURE
FIRST
COUPLING
CLEAVAGE
CONDITIONS
MBHA LL HCl
HATU, DIPEA
DCM, DMF
TFMSA, EDT
thioanisole, TFA
or
HF
H
N
O
O
NH2 OMe
OMe
Rink Amide
HATU, DIPEA
DCM, DMF
95% TFA
scavengers
4-Sulfamyl
butyryl AM N
H
O
S
O O
NH2
DIC, MeIm
DMF, DCM
1. ICH2CN, DIPEA
    or TMSCHN2
2. RNH2, THF
H
N
O
H
N
N
H
Fmoc
4-Fmoc hydrazino
benzoyl AM
HATU, DIPEA
DCM, DMF
1. NBS or DBDMH
    pyridine, DCM
2. RNH2, DCM
 
Table 3: Commercially available resins 
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  First, the Rink Amide resin was used.  This 95 % TFA cleavable linker was hoped to 
withstand treatment of a few equivalents of TFA during the PhF deprotection step, however, the 
linker was only able to withstand one such deprotection, after which, premature degradation of 
the linker was observed.  The 4-sulfamylbutyryl resin was examined also, but it was impossible 
to couple any residue in significant yield to the resin.  Finally the 4-Fmoc hydrazinobenzoyl resin 
was utilized to synthesize the 5-mer (Scheme 27).  Removal of the terminal Fmoc group 
followed by standard solid phase synthesis revealed this linker was stable to both acidic and 
basic conditions, yielding 4.  Activation of the linker for cleavage was accomplished by either N-
bromosuccinimide or N,N-dibromo-2,2-dimethyl-hydantoin in the presence of pyridine with 
dichloromethane as the solvent, giving 5.  Cleavage of the peptide from the resin could then be 
accomplished with various primary amines, in this case, butyl amine.  
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Scheme 27: Synthesis of 5-mer on the hydrazinobenzoyl resin 
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 The resulting peptide 6 was then subjected to triflic acid to remove the Cbz groups, 
revealing the free and flexible oligomer 7, now in 16 % yield (Scheme 28).  Although not 
optimal, this was a substantial increase from 1 %.   
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Scheme 28: Alternate synthesis of closed 5-mer 
 
Oligomer 7 was again incubated in the standard diketopiperazine annealing conditions to 
form scaffold 8.  Unfortunately, this DKP closing reaction was not clean, leaving the scaffold 
contaminated with large amounts of multiple side-products all of the same molecular weight, 
visible by LC-MS analysis.  This suggested that epimerization was taking place during the 
incubation period and causing diastereomeric mixtures to form.   
Epimerization was the second major cause of low yields during oligomer synthesis.  The 
products were always accompanied by a small amount of a diastereomer that must be purified 
away from the product via preparative HPLC.  However, in longer sequences, the amount of 
epimers present in the finished product was prohibitive to further experiments, particularly NMR 
analysis.  
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 Base-catalyzed epimerization of the diketopiperazines is common103,104 and can take 
place by the removal of the acidic proton adjacent to the amide, generating an enolate anion that 
reprotonates equally well from either face, creating a mixture of isomers (Figure 15).  
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Figure 15: Base-catalyzed epimerization of DKP 
 
As a result, testing was done to speed up the DKP-forming reaction of 5-mer 2, under 
basic conditions, such that epimerization might be avoided by less exposure to harsh conditions.  
Table 4 shows the various conditions sampled.  Heating in the microwave reactor for various 
time periods did produce some DKP product 3, but also produced epimers as well.  The addition 
of polar aprotic solvents such as propionitrile can accelerate DKP formation105, but in 80 % 
propionitrile, the oligomer was not soluble. Solvent mixtures of propionitrile and DMF did not 
provide rigidified oligomer. 
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 CONDITIONS TIME TEMPERATURE AMOUNT DKP
20% piperidine
NMP, microwave
20% piperidine
NMP, microwave
20% piperidine
80% propionitrile
20%piperidine
60% propionitrile
20% DMF
15 min
1 h
10 days
10 days
100 C
100 C
RT
RT
none
trace
none
trace
°
°
 
Table 4: Attempted acceleration of DKP formation of compound 2 
 
 Because the basic conditions for DKP annealing proved to be too harsh to provide 
rigidified oligomers cleanly, acidic conditions were investigated as well.  Two short two-mer 
sequences were synthesized on the hydrazino benzoyl resin.  The sequences consisted of 
hin(2S4R7R9R)-pro4(2S4S)-(L)-napthylalanine and pro4(2S4S)-hin(2S4R7R9R)-(L)-
napthylalanine.  The two-mers 9 and 10 were tagged with a napthylalanine residue that closed a 
DKP on the end in 9 but did not close in 10.  The rate of the DKP-closing reaction was much 
slower with the hin(2S4R7R9R) monomer than the pro4(2S4S).  Instead, the free amine was 
capped with a pivalate group.  Both oligomers were then cleaved from the resin with benzyl 
amine and purified before DKP testing. 
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Scheme 29: Two-mer DKP annealing 
 
 Acid catalysis for DKP formation was first observed by Merrifield.106  He proposed a 
bifunctional mechanism (Figure 16) in which the catalytic acid assists in the breakdown of the 
tetrahedral intermediate.  This breakdown is the rate-determining step for aminolysis reactions in 
aprotic media.107  Bifunctional catalysis of the aminolysis process has been extensively 
studied.108, , , ,95 109 110 111
74 
 N
O
NH
H
OR
O N
O
N
H
H
OR
O
O
O
H
N
O
N
H
OR
O
O
OH
H
N
O
N
H
O
 
Figure 16: Acetic acid catalyzed DKP formation 
 
Compound 10 was taken through several sets of DKP annealing conditions.  The microwave 
reactor was used to accelerate the DKP-closing reaction.  Table 5 displays the annealing results.  
Previous studies112 on similar oligomer molecules have shown that the optimal catalytic 
conditions involved 100 mM acetic acid and 50 mM triethylamine.   
REAGENTS SOLVENT TEMP (  C) TIME (h) % CONVERSION
100 mM AcOH
50 mM TEA
NMP 100 1
°
100 mM AcOD
50 mM TEA
100 mM AcOD
50 mM TEA
100 mM AcOH
50 mM TEA
100 mM AcOH
50 mM TEA
o-xylene
o-xylene
o-xylene
o-xylene
100
130
100
100
1
1
1
3
- - -
33
64
71
83
 
Table 5: Microwave DKP annealing of pro4(2S4S)-hin(2S4R7R9R)-napala 
 
 When the reaction was heated in the microwave in NMP for one hour some conversion to 
the closed DKP 12 took place, however decomposition of the solvent accompanied the reaction, 
yielding inadequate results.  However, when o-xylene was chosen as the solvent, no 
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 decomposition was observed and very clean conversion took place.  Deuterated acetic acid was 
used in several runs to determine if any epimerization took place.  If any epimerization occurred, 
then the oligomer should pick up a deuteron from solution, which would be visible via mass 
spectrometry.  Nonetheless, no epimerization was detected under these acidic conditions.   
 Similar results were obtained for the other two-mer 9.  After two hours in the microwave 
reactor, conversion to the closed DKP 11 reached 79 %.  Conversion could be pushed to near 
completion by running the reactions for longer periods of time; however this was not practical 
for a microwave reactor.  Thus, a high temperature incubator was used to complete the annealing 
reactions at 100 °C for a period of over six hours.   
 From these encouraging results, two longer oligomer sequences were synthesized for 
annealing under these conditions.  Again, the same 5-mer sequence (as in Figure 14) was 
assembled along with another sequence of six monomers that formed an interesting triangular 
shape (Figure 17).  This oligomer, consisted of the sequence pro4(2S4S)-pro4(2S4S)-
hin(2S4R7R9R)-pro4(2R4S)-hin(2S4R7R9R)-pro4(2S4S), including the two previously discussed 
monomers, in addition to the pro4(2R4S) diastereomer.  The triangular structure of this rigidified 
oligomer could be used in future applications where two functional or catalytic groups are held 
in close proximity to one another on the ends of the scaffold. 
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     Top View           Side View 
Figure 17: A six-mer triangular macromolecule 
 
 Unfortunately, neither oligomer was soluble in o-xylene.  Addition of DMF as a co-
solvent did improve the solubility of the oligomers, however clean conversion to the DKP closed 
oligomer did not take place under mixed solvent conditions.  As a result, after much difficulty 
and exhaustive experimentation on improving the solution-phase DKP annealing reaction, a new 
strategy was employed.   
 This new strategy had to be fast, high yielding, without any side reactions and be 
applicable to longer sequences.  On-resin DKP closure was very appealing for these reasons.  
Additionally, there would be no solubility problems, forcing conditions could be used to drive 
the reaction to completion, and the catalysts and byproducts could be filtered and washed away.  
However, with the current protecting group scheme used for the hin(2S4R7R9R) building block, 
it was impossible to close the diketopiperazines with the oligomer still bound to the resin.  The 
Cbz protecting group can only be removed via hydrogenolysis or under very acidic conditions, 
two processes that cannot be done on solid support.  Therefore, it was necessary to change the 
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 nitrogen protecting groups of the hin(2S4R7R9R) monomer to those more suitable for on-resin 
DKP closure. 
 The PhF group was removed by treatment of the hin(2S4R7R9R) monomer 13 with five 
equivalents of TFA in dichloromethane with methanol present as a cation scavenger.  The free 
amine was then protected with an Fmoc group in good yield, resulting in 14.  The Cbz group was 
then removed via hydrogenolysis over Pd/C.  The resulting secondary amine was protected with 
a Boc group to yield another differentially protected hydroindole monomer 15.   
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Scheme 30: Another hin monomer 
 
 As done previously, the monomer was then incorporated into a two-mer sequence 16 on 
solid support (Scheme 31).  In this case, a hydroxymethyl polystyrene resin (Novabiochem) was 
used.  This resin proved to be a bit more acid labile during the cleavage reaction with triflic acid, 
providing increased yields of oligomer.  A bromophenyl alanine residue was first coupled to the 
resin to act as a mass spectral tag for the oligomer.  The bromine containing residue allows the 
tracking of oligomers via the characteristic M and M+2 molecular ions seen in the mass 
spectrum due to the approximate 1:1 relative abundances of 79Br and 81Br isotopes.  In addition, a 
napthylalanine was coupled to the leading end of the two-mer as a potent UV chromophore.  The 
pro4(2S4S) monomer, this time containing a Boc group in place of a Cbz protecting group, was 
also used.  After assembly of 16 on resin, the Boc groups were removed by treatment of the resin 
with TFA for 15 minutes, followed by a neutralization to yield the free amino compound 17.  
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 The oligomer-containing resin was then placed into the microwave reactor under various 
conditions to evaluate the closing of the DKP moiety.       
N
H
H
CO2Me
N
N
OO H
16
NH
NH
HN
N
O
H
H O
O
HN
NH
O
O
H
N
N
H
H
NO
O
18
O
O
Br
O
O
Br
NH
NH
HN
N
O
H
H O
O
N
H
H
NO
O
19
O
OH
Br
H
N
H
H
CO2Me
N
HN
OO H
17
HN
NH
O
O
H
N
O
O
Br
Boc Boc 1. 50% TFA, DCM
2. 10% DIPEA, DCM
μW
TFMSA, EDT,
thioanisole, TFA
 
Scheme 31: On resin microwave closure of a two-mer 
 
 The standard conditions (100 mM AcOH, 50 mM TEA, o-xylene) were applied and the 
reaction was heated to 130 °C for 30 minutes.  After this time period, a small portion of the resin 
18 was treated with triflic acid cleavage conditions and analyzed by LC-MS.  The MS revealed 
18 % conversion to compound 19.  Raising the temperature to 180 °C for 90 minutes in the 
microwave pushed conversion to 72 %, but the best solvent in which to perform the microwave 
reaction was o-dichlorobenzene at a temperature of 250 °C for 60 minutes.  The DKP was 
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 completely closed with no visible starting material or epimerization.  These astonishing 
conditions have accelerated the DKP half-life from days to minutes! 
 The opposite two-mer sequence 20 was synthesized as well, but no starting material or 
product was obtained after workup.  This was probably due to self-cleavage of the two-mer from 
the resin as shown in Scheme 32.  In the case of 18 this self-cleavage does not occur, most likely 
due to the steric effects of the hin(2S4R7R9R) building block.  Self-cleavage can be avoided in 
the future by coupling the monomer directly to the resin without first attaching an amino acid or 
by using a resin with an amide linker.   
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Scheme 32: Probable self cleavage of a two-mer from the hydroxymethyl resin 
 
4.3. Conclusions 
After much experimentation, the best solid-phase resins for the synthesis of the oligomers 
have been discovered.  The ideal DKP-closing conditions were found that do not give any 
epimerization and yield very clean products.  This knowledge will allow for the synthesis of the 
longer 5-mer and 6-mer sequences and provide enough rigidified material for NMR and other 
analyses.  In the future, this technology should permit the assembly of longer, more complex and 
functional macromolecules of well defined architectures. 
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 4.4. Experimental Section 
General: THF was distilled from Na/benzophenone under N2.  DCM was distilled from CaH2.  
All other reagents were used as received unless otherwise noted.  All reactions were carried out 
in flame-dried or oven-dried glassware under N2 atmosphere unless otherwise noted.  Column 
chromatography was performed using ICN Silitech 32-63 D (60 A) grade silica gel and TLC 
analysis was performed on EM Science Silica Gel 60 F254 plates (250 μm thickness).  NMR 
experiments were performed on either Bruker Avance 300 MHz or Bruker Avance DRX 500 
MHz spectrometers.  Chemical shifts (δ) are reported relative to CDCl3 or DMSO-d6 residual 
solvent peaks, unless otherwise noted.  If possible, rotational isomers were resolved by obtaining 
spectra above 100 °C in DMSO-d6 at the below indicated temperatures.  IR spectra were 
obtained on a Nicolet Avatar E.S.P. 360 FT-IR.  Optical rotations were obtained on a Perkin-
Elmer 241 polarimeter at the indicated temperatures.  EI-MS was performed on a Micromass 
Autospec high resolution mass spectrometer (CEBE geometry).  High resolution ESI-MS was 
performed on a Waters LC/Q-TOF instrument.  HPLC analysis was performed on a Hewlett-
Packard Series1050 instrument with diode array detector, using a Varian Chrompack Microsorb 
100 C18 column (5 μm packing, 2.6 mm x 250 mm).  HPLC-MS analysis was performed  on an 
Agilent LC/MSD SL instrument (ESI).  
 
Solid phase chemistry was performed using a home made manual synthesizer.  Dry 
dichloromethane was obtained from distillation over CaH2.  Anhydrous DMF was purchased 
from Aldrich Chemical Company.  Diisopropylethyl amine (DIPEA) was distilled from 
ninhydrin and potassium hydroxide and stored over molecular sieves (4 A).  O-(7-
azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU) was 
obtained from Acros.  MBHA•LL HCl, MHBA-Y-Boc, Fmoc-hydrazino benzoyl, rink amide, 
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 and 4-sulfamylbutyryl resins were purchased from NovaBiochem.  All solid phase reactions 
were mixed by bubbling Ar through the reaction vessel and continuously kept under Ar 
atmosphere. 
(L)-tyrosine-pro4(2S4S)-hin(2S4R7R9R)-pro4(2S4S)-hin(2S4R7R9R)-pro4(2S4S)=glycine 
(2).   
To a 5 mL polypropylene solid phase peptide synthesis (SPPS) reactor vessel was added 
MBHA·LL·HCl Resin (169 mg, 104 μmol loading).  The resin was swelled for 2 h in dry DMF 
under Ar atmosphere.  To a 15 mL Falcon tube were added N-Boc-2-BrZ-L-tyrosine (103.5 mg, 
209.4 μmol), HATU (79.6 mg, 209 μmol), DMF (200 μL), DCM (800 μL) and DIPEA (73.0 μL, 
418 μmol).  The mixture was vortexed for 1 min to ensure activation of the amino acid and then 
immediately transferred to the resin.  The coupling reaction was mixed for 30 min and the 
solution drained from the beads.  The terminal Fmoc protected amine of the tyrosine was 
deblocked by treatment with 20 % piperidine/DMF (2 mL) over 2 h.  The resin was then washed 
three times with fresh DMF (1 mL) and subjected to a second coupling reaction under identical 
conditions.  The resin was washed again three times with DMF (1 mL). 
 
To a 15 mL Falcon tube were added pro4(2S4S) monomer (114 mg, 209 μmol) and HATU (79.6 
mg, 209 μmol).  DCM (800 μL) and DMF (200 μL) were added.  DIPEA (73.0 μL, 418 μmol) 
was added and the solution was vortexed for 1min to initiate activation of the building block.  
The homogeneous solution was then added immediately to the solid phase resin.  The coupling 
reaction was mixed for 30 min and the solution drained from the resin.  The resin was then 
washed three times with fresh DMF (1 mL) and subjected to a second coupling reaction under 
identical conditions.  The resin was washed again three times with DMF (1 mL).  The terminal 
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 Fmoc protected amine of the building block was deblocked by treatment with 20 % 
piperidine/DMF (2 mL) over 25 min.  The resin was washed three times with DMF (1 mL). 
 
To a 15 mL Falcon tube were added hin(2S4R7R9R) monomer (129 mg, 209 μmol) and HATU 
(79.6 mg, 209 μmol).  DCM (800 μL), DMF (200 μL) and DIPEA (73.0 μL, 418 μmol) were 
added and the solution vortexed for 1 min to initiate activation of the building block.  The 
homogeneous solution was then immediately pipetted onto the solid phase resin.  The coupling 
reaction was mixed for 30 min and the solution drained from the resin.  The resin was then 
washed twice with fresh DMF (1 mL) and subjected to a second coupling reaction under 
identical conditions.  The resin was washed again with DMF (1 mL).  The terminal PhF 
protected amine of the building block was deblocked by treatment with 50 % TFA/DCM (500 
μL) over 15 min.  The resin was washed twice with DCM (1 mL), neutralized (20 % 
DIPEA/DCM, 400 μL) and washed twice with DMF (1 mL).   
 
The above mentioned coupling and deprotection sequences were performed again under identical 
conditions twice for the pro4(2S4S) and once for hin(2S4R7R9R) monomer.   
 
To a 15 mL Falcon tube were added Fmoc-glycine (62.2 mg, 209 μmol), HATU (79.6 mg, 209 
μmol), DMF (200 μL), DCM (800 μL) and DIPEA (73.0 μL, 418 μmol).  The mixture was 
vortexed for 1 min to ensure activation of the amino acid and then immediately transferred to the 
resin.  The coupling reaction was mixed for 30 min and the solution drained from the beads.  The 
terminal Fmoc protected amine of the tyrosine was deblocked by treatment with 20 % 
piperidine/DMF (2 mL) over 2 h.  The resin was then washed three times with fresh DMF (1 
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 mL) and subjected to a second coupling reaction under identical conditions.  The resin was 
washed twice with DMF, twice with DCM, twice with methanol and twice again with DCM.  
The oligomer-containing resin was then dried under vacuum at room temperature overnight. 
 
Deprotection of the Cbz groups of the oligomer, tert-butyl protecting group of the tyrosine 
hydroxyl and cleavage of the oligomer from the resin were done by treatment with a cleavage 
solution containing TFA (500 μL), thioanisole (50 μL), ethane dithiol (25 μL) and 
trifluoromethane sulfonic acid (50 μL) for 2.5 h first at 0 °C for one hour and then room 
temperature with magnetic stirring.  The cleavage solution was drained into a centrifuge tube 
containing an excess volume of diethyl ether (35 mL), whereupon the oligomer precipitated as a 
white solid.  The resin was washed with an additional portion of TFA (250 μL) and that volume 
also drained into the ether.  The solution was centrifuged (9000 rpm, 30 min), the supernatant 
decanted and the residue washed with an additional portion of ether.  The white solid was dried 
in vacuo and the product purified by preparative HPLC on a Varian Prostar instrument with 
photodiode array detector (10-35 % MeCN:H2O over 30 min, flow = 15 mL/min, UV detection = 
274 nm).  The product containing fractions were lyophilized to remove the solvent, yielding a 
fluffy white powder. HPLC: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV 
detection = 274 nm, tR = 8.97 min; LC-MS (ESI) calculated for C53H74N13O17 (M+H) 1164.3, 
found 1164.3. 
(L)-tyrosine-pro4(2S4S)=hin(2S4R7R9R)=pro4(2S4S)=hin(2S4R7R9R)=pro4(2S4S)=glycine 
(3).   
A solution of (2) in approximately 1 mL of 20 % piperidine/DMF was incubated at 50 °C for 11 
days.  The reaction progress was monitored by HPLC-MS.  The reaction mixture was then added 
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 dropwise to a centrifuge vial containing an excess volume of diethyl ether (35 mL) to precipitate 
the product.  The vial was centrifuged (9000 rpm, 30 min), the supernatant decanted and the 
residue purified by preparative HPLC on a Varian Prostar instrument with photodiode array 
detector (10-35 % MeCN:H2O over 30 min, flow = 15 mL/min, UV detection = 274 nm).  The 
product containing fractions were lyophilized to remove the solvent, yielding a fluffy white 
powder. HPLC-MS: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV detection = 
274 nm, tR = 7.68 min, HR-MS (ESI) calculated for C49H58N13O13 (M+H) 1036.4272, found 
1036.4301. 
Bu-(L)-tyrosine-pro4(2S4S)-hin(2S4R7R9R)-pro4(2S4S)-hin(2S4R7R9R)-pro4(2S4S)-
glycine (7).   
The oligomer was synthesized in the exact same manner as 2 on the hydrazino benzoyl resin on a 
12.69 μmol scale.  Capping between each coupling was done with pivalic anhydride.  The 
flexible oligomer was cleaved from the resin by a two step procedure.  The resin was first treated 
with a solution (DCM, 1 mL) of DBDMH (3.60 mg, 12.7 μmol) and pyridine (2.07 μL, 25.4 
μmol) for 10 min at room temperature.  The solution was then drained from the resin and the 
beads washed three times with fresh DCM (1 mL).  The beads were then treated to a solution 
(DCM, 1 mL) of butyl amine (12.5 μL, 127 μmol) for 4 hours with magnetic stirring.  The 
solution was drained from the resin and the DCM removed in vacuo.  The resulting yellow oil 
was treated with EDT (25 μL), thioanisole (50 μL), TFA (500 μL), and TFMSA (50 μL).  The 
solution was allowed to stir for 1.5 h and then dripped into a large volume of diethyl ether (35 
mL).  The ppt (2.45 mg, 15.8 %) was centrifuged, the supernatant decanted, and the residue dried 
in vacuo.  HPLC: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV detection = 
274 nm, tR = 7.40 min; LC-MS (ESI) calculated for C57H82N13O17 (M+H) 1220.1, found 1220.1. 
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 Bu-(L)-tyrosine-pro4(2S4S)=hin(2S4R7R9R)=pro4(2S4S)=hin(2S4R7R9R)=pro4(2S4S)= 
glycine (8).   
A solution of (7) in approximately 1 mL of 20 % piperidine/DMF was incubated at 50 °C for 11 
days.  The reaction progress was monitored by HPLC-MS.  The reaction mixture was then added 
dropwise to a centrifuge vial containing an excess volume of diethyl ether (35 mL) to precipitate 
the product.  The vial was centrifuged (9000 rpm, 30 min), the supernatant decanted.  HPLC-
MS: MeCN/H2O 5-95 % over 30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, tR = 
10.97 min, LC-MS (ESI) calculated for C53H66N13O13 (M+H) 1092.2, found 1092.2. 
Bn-hin(2S4R7R9R)-pro4(2S4S)=(L)-napala (9).   
Synthesized on hydrazino benzoyl resin (16.17 μmol scale).  HPLC-MS: MeCN/H2O 5-95% 
over 30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, tR = 9.86 min, LC-MS (ESI) 
calculated for C37H43N6O6 (M+H) 667.3, found 667.0. 
Bn-pro4(2S4S)-hin(2S4R7R9R)-(L)-napala-piv (10).   
Synthesized on hydrazino benzoyl resin (19.50 μmol scale).  HPLC-MS: MeCN/H2O 5-95 % 
over 30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, tR = 12.97 min, LC-MS (ESI) 
calculated for C43H55N6O8 (M+H) 783.4, found 783.2. 
Bn-hin(2S4R7R9R)=pro4(2S4S)=(L)-napala (11).   
HPLC-MS: MeCN/H2O 25-55 % over 30 min, flow rate = 0.30 mL/min, UV detection = 274nm, 
tR = 4.72 min, LC-MS (ESI) calculated for C36H39N6O5 (M+H) 635.0, found 635.0. 
Bn-pro4(2S4S)-hin(2S4R7R9R)-(L)-napala-piv (10).   
HPLC-MS: MeCN/H2O 25-55 % over 30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, 
tR = 13.93 min, LC-MS (ESI) calculated for C42H51N6O7 (M+H) 751.1, found 751.2. 
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 Typical solution phase microwave DKP closing experiment.   
A small volume of a solution of the oligomer was placed into a GC vial and the solvent removed 
in vacuo.  The dried residue was then placed into a microwave reactor vessel containing another 
GC vial.  The reactor vessel was filled with a few mL (2-3) of reaction solvent and catalysts.  
Approximately 200 μL of reaction solvent was placed into the GC vial containing the oligomer 
and the vessel sealed with a pressure cap.  The reaction was run in the microwave for the desired 
length of time and the resulting reaction volume was pipetted directly into another GC vial for 
LC-MS analysis.   
Typical on-resin DKP closing experiment.   
The oligomer-containing resin was transferred directly to a microwave reactor vessel with a 
small magnetic stir bar.  Approximately 3 mL of reaction solvent and catalysts were pipetted 
directly onto the beads.  The vessel was sealed and run in the microwave for a specific time 
length.  The beads and reaction solution were pipetted into a SPPS reactor vessel and the solution 
drained from the resin.  The beads were washed 3x with DMF, 3x with iPrOH, and 3x with 
DCM.  The dried resin was then taken onto the appropriate cleavage step and the precipitated 
oligomer injected onto the LC-MS for analysis. 
(2S,4R,7R,9R)-7-(9H-Fluoren-9-ylmethoxycarbonylamino)-octahydro-indole-1,2,7-
tricarboxylic acid 1-tert-butyl ester 7-methyl ester (15).   
To a solution of hin(2S4R7R9R) in DCM (10 mL) and MeOH (137 μL, 3.39 mmol) was added 
TFA (421 μL, 5.65 mmol).  The mixture was stirred at RT for 20 min.  The solvent was removed 
in vacuo and the crude material taken on directly to the next step.  To a suspension of the amine 
in DCM (10 mL) was added DIPEA (984 μL, 5.65 mmol) and TMSCl (356 μL, 2.82 mmol).  
The mixture was refluxed for 1.5 h and then transferred to an ice bath.  FmocCl (292 mg, 1.13 
87 
 mmol) was added and the reaction was allowed to warm to RT overnight.  The mixture was 
rotovapped, dissolved in EtOAc, washed 2x with 1 M aq. HCl and the aqueous layers back 
extracted with EtOAc.  The combined organic layers were washed with brine, dried (Na2SO4), 
filtered and concentrated.  The residue was purified on SiO2 (1:1 EtOAc:hex followed by 9:1 
CHCl3:MeOH, 1 % AcOH).  The product 14 was isolated as a white foam (595 mg, 88 %).  To a 
solution of compound 14 (326 mg, 0.545 mmol) in MeOH (10 mL) was added 32.6 mg of Pd/C.  
The suspension was purged and flushed 4x with hydrogen.  The reaction was allowed to stir 
under an H2 balloon for 2 h.  The mixture was filtered, rotovapped, and carried on crude to the 
next step.  To a suspension of the amino acid in DCM (10 mL) was added TMSCl (276 μL, 2.18 
mmol).  The solution was refluxed for 1 h, transferred to an ice bath, and DIPEA (759 μL, 4.36 
mmol) and Boc2O (238 mg, 1.09 mmol) added.  The mixture was allowed to warm to RT 
overnight.  The solution was rotovapped, dissolved in EtOAc, and washed 2x with 5 % aq. 
NaHSO4.  The aqueous layer was extracted with EtOAc and the combined organic layers washed 
with brine, dried (Na2SO4), filtered and concentrated.  The residue was purified on SiO2 (5% 
MeOH:CHCl3 followed by 10 % MeOH:CHCl3).  The product 15 was isolated as a white foam 
(155 mg, 50 %).  [α]20D = -22.8 (c= 0.54, DCM); IR (neat) 3415, 2083, 1670, 1409, 1258, 1233, 
1168, 1131, 1045 cm-1; 1H NMR (300 MHz, CDCl3) (~2:1 mixture of rotamers) δ 7.77 (d, 2H, J 
= 7.4 Hz), 7.58 (d, 2H, J = 7.1 Hz), 7.29-7.43 (m, 4H), 4.30-4.46 (m, 3H), 4.20 (br t, 2H, J = 6.8 
Hz), 3.73 (br s, 3H), 2.90-2.97 (m, 1H), 2.32-2.55 (m, 2H), 1.90-2.22 (m, 3H), 1.60-1.82 (m, 
2H), 1.45 (s, 4.5H), 1.41 (s, 4.5H), 0.82-0.94 (m, 1H); 13C NMR (125 MHz, CDCl3) (~2:1 
mixture of rotamers) δ 178.7, 177.9, 175.6, 172.8, 155.5, 143.7, 141.2, 136.1, 128.3, 127.6, 
127.0, 124.9, 119.9, 81.3, 80.8, 67.3, 66.6, 58.9, 58.6, 58.3, 55.2, 55.0, 52.5, 52.4, 47.0, 34.5, 
88 
 33.6, 32.9, 30.8, 30.5, 29.6, 28.8, 28.2, 28.1, 21.7; LC-MS (ESI) calculated for C26H28N2O6 
(M+1-Boc) 464.2, found 464.8. 
BrPhe-hin(2S4R7R9R)=pro4(2S4S)=(L)-napala (19).   
The two-mer was synthesized using previously established peptide synthesis chemistry.  On resin 
compound 16 was treated with a 50 % TFA/DCM solution for 15 minutes to remove the Boc 
protecting groups.  The resin was neutralized with 10 % DIPEA/DCM (1 mL), washed 3x with 
DMF, 3x with iPrOH, and 3x with DCM.  The resin was then dried in vacuo.  The beads were 
subjected to microwave conditions as previously described and cleaved using standard TFMSA 
conditions.  Compound 19 was then analyzed via LC-MS.  HPLC-MS: MeCN/H2O 5-95 % over 
30 min, flow rate = 0.30 mL/min, UV detection = 274 nm, tR = 12.11 min, LC-MS (ESI) 
calculated for C38H40BrN6O7 (M+2) 772.2, found 772.0. 
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APPENDIX A 
Crystallographic Data for Trichloromethyl Carbinol 8 
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   Table 1.  Crystal data and structure refinement for steveh. 
Identification code  steveh 
Empirical formula  C19 H22 Cl3 N O5 
Formula weight  450.73 
Temperature  100.0(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 6.0300(12) Å α= 90°. 
 b = 11.333(2) Å β= 90°. 
 c = 29.296(6) Å γ = 90°. 
Volume 2002.0(7) Å3 
Z 4 
Density (calculated) 1.495 Mg/m3 
Absorption coefficient 0.489 mm-1 
F(000) 936 
Crystal size 0.26 x 0.14 x 0.07 mm3 
Theta range for data collection 1.93 to 32.61°. 
Index ranges -9<=h<=9, -17<=k<=17, -43<=l<=42 
Reflections collected 25765 
Independent reflections 7033 [R(int) = 0.0758] 
Completeness to theta = 32.61° 97.8 %  
Absorption correction Sadabs 
Max. and min. transmission 0.9666 and 0.8834 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7033 / 0 / 342 
Goodness-of-fit on F2 1.148 
Final R indices [I>2sigma(I)] R1 = 0.0613, wR2 = 0.1248 
R indices (all data) R1 = 0.0708, wR2 = 0.1286 
Absolute structure parameter 0.10(6) 
Largest diff. peak and hole 0.823 and -0.385 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for steveh.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
N 3502(4) 2623(2) 6835(1) 11(1) 
Cl(1) 1121(1) 1780(1) 8981(1) 17(1) 
O(1) 4370(4) 1162(2) 6063(1) 23(1) 
C(1) 5714(4) 2158(2) 6744(1) 11(1) 
Cl(2) -24(1) 3854(1) 8474(1) 17(1) 
O(2) 7988(4) 1618(2) 6137(1) 20(1) 
C(2) 5995(4) 1217(2) 7122(1) 13(1) 
Cl(3) 4558(1) 3220(1) 8598(1) 19(1) 
O(3) -443(3) 1472(2) 8009(1) 13(1) 
C(3) 3613(5) 813(2) 7209(1) 13(1) 
O(4) 863(3) 4017(2) 6693(1) 16(1) 
C(4) 3253(5) 108(2) 7647(1) 16(1) 
O(5) 4012(3) 3873(2) 6268(1) 14(1) 
C(5) 3397(5) 859(2) 8079(1) 13(1) 
C(6) 1765(4) 1884(2) 8055(1) 10(1) 
C(7) 2293(5) 2655(2) 7643(1) 14(1) 
C(8) 2297(4) 1975(2) 7192(1) 12(1) 
C(9) 5868(5) 1590(2) 6271(1) 15(1) 
C(10) 8471(7) 1053(3) 5705(1) 32(1) 
C(11) 1856(4) 2644(2) 8501(1) 12(1) 
C(12) 2630(4) 3540(2) 6606(1) 12(1) 
C(13) 3200(5) 4812(2) 5980(1) 17(1) 
C(14) 4792(5) 4991(2) 5592(1) 15(1) 
C(15) 4360(6) 5932(3) 5299(1) 24(1) 
C(16) 5816(6) 6185(3) 4944(1) 29(1) 
C(17) 7667(7) 5512(3) 4877(1) 30(1) 
C(18) 8099(6) 4570(3) 5165(1) 27(1) 
C(19) 6663(5) 4315(3) 5523(1) 21(1) 
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 ORTEP Figure from crystal data 
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APPENDIX B 
2D NMR Data for pro4(2S4S)=hin(2S4R7R9R)=pro4(2S4S)=(L)-tyr 
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Spectrum:  cosy_12
User:  meister     Date:  Sun Jul 18 17:06:49 2004
Positive contours: low 7.75e+004  levels 11  factor 1.69
Negative contours: low -3.40e+004  levels  1  factor 1.40
Supplemental figure 12
2D-COSY of compound 3, focused in aliphatic/aliphatic region
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
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Negative contours: low -3.40e+004  levels  1  factor 1.40
Supplemental figure 13
2D-COSY of compound 3, entire spectrum
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
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Supplemental figure 14
2D-HMQC of compound 3
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
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Supplemental figure 15
2D-HMBC of compound 3
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
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Supplemental figure 16
2D-HMBC of compound 3
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
99
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Supplemental figure 17
2D-HMBC of compound 3
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
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Supplemental figure 18
2D-HMBC of compound 3
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
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Supplemental figure 19
2D-ROESY of compound 3, positive contours=RED, negative contours=GREEN
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
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Supplemental figure 20
2D-ROESY of compound 3, positive contours=RED, negative contours=GREEN
80% H2O/ 10% D2O/ 10% CD3CN buffered with 45 uM CD3COOD/ND3 pH=~5
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